Dr. Kutsenko is an Interventional Radiology Chief Resident at the Miami Cardiac and Vascular Institute. She completed medical school at the Medical University of Lublin, graduating with the highest honors. Following medical school, she underwent internal medicine and diagnostic radiology residency training at the State University of New York Upstate Medical University.

Oleksandra actively engages in the development of interventional radiology serving in the SIR Comparative Effectiveness Research Committee, Women’s Health Council, Economics Committee, and Carrier Advocacy Workgroup. She has published a textbook chapter and multiple scientific and review articles and presented her research at numerous national and international conferences.

Jose Hugo Luz

Interventional Radiologist (MD, EBIR, CIRSE Fellow)

Rio de Janeiro, Brazil

About

Interventional Radiologist
Research in Liver Regeneration, Liver Cancer, Portal Vein Embolization.

Experience

Médico e Sócio da Empresa RIVOAMédico e Sócio da Empresa RIVOA

RIVOA · Part-timeRIVOA · Part-timeSep 2021 – Present · 1 yr 4 mosSep 2021 – Present · 1 yr 4 mosRio de Janeiro, Rio de Janeiro, BrasilRio de Janeiro, Rio de Janeiro, Brasil

Chefe do Serviço de Radiologia Intervencionista do INCA,

Instituto Nacional de Câncer · Part-time Rio de Janeiro, Brasil

• • Departamento de Radiologia Intervencionista do INCADepartamento de Radiologia Intervencionista do INCA

Medical Doctor Interventional RadiologistMedical Doctor Interventional Radiologist

Curry Cabral Hospital. Centro Hospitalar Universitário Lisboa central, Lisboa e Região, Portugal

• • Interventional Radiologist at Curry Cabral Hospital. Lisbon. Portugal. The unit is dedicated to treat liver disease, but it is also involved in the treatment of other areas such as oncology, vascular disease, acute bleedings and other fields.

Medico Radiologista IntervencionistaMedico Radiologista Intervencionista

RVORVO

Radiologista Intervencionista

Instituto Nacional de Câncer, Rio de Janeiro

Education

Universidade Nova de LisboaUniversidade Nova de Lisboa

Doutoramento PhD, Pesquisa Clínica

Grade: Doutoramento em Medicina / PhDGrade: Doutoramento em Medicina / PhD

Instituto Nacional de CâncerInstituto Nacional de Câncer

Radiologista Intervencionista / Mestrado em Oncologia, Medicina

Licenses & certificationsLicenses & certifications

European Board of Interventional Radiology (EBIR)

Cardiovascular and Interventional Radiological Society of Europe

Overview

Leonardo Azevedo Rodrigues,

Is an Interventional Radiologist specialized in Oncology at Gavearad Radiologia, Rio de Janeiro, Brazil

Experience

• Partner / Interventional Radiologist

            Gavearad Radiologia Vascular E IntervencionistaGavearad Radiologia           Vascular E Intervencionist, Rio de Janeiro, Brazil

• Observer

            Gustave Roussy Villejuif, Île-de-France

• Observer

            CHRU de Strasbourg – Hôpitaux Universitaires de Strasbourg CHRU de        Strasbourg, Strasbourg, France

Education

• Instituto Nacional do Câncer

            Vascular and Interventional Radiology Residency Program.

• Faculdades Souza Marques,

Doctor of Medicine

So Lyung Jung is an academic researcher from Catholic University of Korea.  has contributed to research in topic(s): Thyroid nodules & Fine-needle aspiration.

She has an index of 3, co-authored 3 publication(s) receiving 991 citation(s).

Dr. Shivanand Gamanagatti

Qualifications : M.D, MAMS, FICR

Designation : Professor of Radiology, AIIMS, New Delhi

Area of  Interest : Trauma & MSK Radiology and Interventional Radiology

Publications: 250 publications in  various  National and International Journals, more than 100 scientific  presentations  and delivered  more than 100 lectures in national and international conferences. Written many chapters in Radiology text books

Awards

David M. Levi, MD, FACS, is a Transplant Surgeon at Atrium Health Carolinas Medical Center in Charlotte, North Carolina. He is currently a Clinical Professor at Wake Forest University School of Medicine in the Department of Surgery.  Dr. Levi completed his undergraduate studies at Wabash College in Indiana.  He attended medical school at the University of Miami Miller School of Medicine and completed his residency training at UM/JMH.  He completed his multi-organ transplant surgery fellowship at UM/JMH.  In 1999, he joined the faculty in the Daughtry Family Department of Surgery at the University of Miami.  His clinical, educational, and research contributions earned him the rank of Professor of Clinical Surgery.  He moved to Charlotte, NC in 2012 to focus on adult and pediatric liver transplantation at CMC.  In 2022, he was named a Clinical Professor of Surgery at Wake Forest University School of Medicine.  He has authored or co-authored more than 160 peer reviewed publications and book chapters concentrated in the areas of liver transplantation and hepatobiliary surgery.  He has presented his work at nationally and internationally.  He has a particular interest in the multidisciplinary management of hepatocellular carcinoma, transplant oncology, as well as adult and pediatric liver transplantation.  Dr. Levi is a member of multiple societies, including the Southern Surgical Association, and has served on various committees in the American Society of Transplant Surgeons.  He is board certified by the American Board of Surgery and is a Fellow of the American College of Surgeons.

Peter Littler is a Consultant Interventional Radiologist with an interest in Interventional Oncology, leading a regional service for liver ablation, TACE and SIRT. Peter is the Secretary of IOUK and was the Chair of the Scientific Programme Committee for BSIR Annual Scientific Meeting 2021.

Dr Phil Haslam

Dr Haslam is a Consultant Interventional and Uroradiologist based at the Freeman Hospital in Newcastle upon Tyne and is President of the British Society of Interventional Radiology.

He has interests in interventional and uroradiology, with experience in a wide variety of imaging techniques for the kidneys, bladder, prostate gland, arteries and veins.

Dr Haslam  has been chairman of the British Society of Urogenital Radiology and was a founding member of IOUK (Interventional Oncology UK). He is the founder and Editor in chief of Which Medical Device, an independent educational and review website for medical devices and procedures.

Daniel B. Brown is Vice-Chair of Innovation and Clinical Research at Vanderbilt University Medical Center.

He is a Professor of Radiology and Biomedical Engineering and Director of Interventional Oncology.

Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Iwate Medical University, March 2021

Associate Professor, Division of Hepatology, Department of Internal Medicine, Iwate Medical University, March 2018

Research Fellow, Imperial College London, Department of Medicine, Hepatology, March 2013

Assistant Professor, Iwate Medical University, March 2003

Research Student, Department of Gastroenterology, University of Tokyo, March 2001

Ph.D., Iwate Medical University, March 2001

William S. Rilling

Born and raised in Milwaukee, Wisconsin, I received my undergraduate degree in

Biochemistry and MD  from the University of Wisconsin.  My transitional internship

was at Virginia Mason Hospital in Seattle, Washington followed by radiology residency

at the Medical College of Wisconsin. After my Interventional Radiology Fellowship at

Northwestern Hospital in Chicago, Illinois , I returned to join the IR faculty at the Medical College of Wisconsin.

I am fortunate to have three wonderful children : Nicholas age 9 , Gabrielle age 5, and

Nate age 4, and my wife Kate who give me constant joy and good reasons to get out of

the hospital.

Robert J. Lewandowski, M.D., FSIR, is a Professor of Radiology, Medicine, and Surgery in the Feinberg School of Medicine at Northwestern University. He serves as the Director of Interventional Oncology at the Northwestern University Robert H. Lurie Comprehensive Cancer Center. Dr. Lewandowski joined the staff at Northwestern in 2006 upon completion of his fellowship training in Vascular and Interventional Radiology. Dr. Lewandowski is a practicing interventional radiologist who specializes in liver-directed therapy. Based on his clinical oncology program, he has authored or co-authored > 150 articles for peer-reviewed journals on the application of liver-directed therapies for patients with gastrointestinal malignancies. Dr. Lewandowski also performs pre-clinical oncology research in the Northwestern University Interventional Oncology Laboratory and Center for Translational Imaging. In this capacity, he is developing and evaluating novel oncology therapeutics, delivery mechanisms, and imaging modalities. Dr. Lewandowski’s work has been supported by the National Institute of Health, American Cancer Society, the Society of Interventional Radiology Foundation, and through industry collaboration via the investigator-initiated trial mechanism.

Dr. Jack Jennings is a Professor in the Department of Radiology and Orthopaedic Surgery at Washington University’s Mallinckrodt Institute of Radiology and serves as the Chief of Musculoskeletal Radiology and Director of Musculoskeletal and Spine Intervention.

Dr. Jennings has co-authored over 90 peer-reviewed journal articles, review articles, and book chapters. He is an active manuscript reviewer for such journals as Radiology, American Journal of Radiology, Skeletal Radiology, Journal of Vascular Interventional Radiology, American Journal of Neuroradiology and Cardiovascular and Interventional Radiology.  He has done over 100 invited lectureships with the majority focusing on musculoskeletal and spine tumor ablation.  He co-created the multi-disciplinary metastatic spine disease working group in Dallas 2014 composed of  recognized experts in the fields of medical, radiation, and surgical oncology and interventional radiology which led to the published algorithms and recommendations for the treatment of metastatic spine disease, including percutaneous tumor ablation.

Dr. Jennings has presented at several national and international radiology and musculoskeletal/orthopedic society meetings, including ASSR, ASNR, ISS, SSR, RSNA, SIO, WFITN, ECIO, WOA, CIRSE, and APSCVIR. He is an active member in these societies including serving on Executive, Program, Clinical Practice, Nominating and Informatics Committees. He is the current president of the American Society of Spine Radiology. Dr. Jennings main research interest lies in musculoskeletal and spine tumor ablation, bone and soft tissue biopsies, and osteoporotic and pathologic fracture treatment. He has been involved in multiple funded prospective studies and has been both the institutional and overall Principal Investigator on bone and spine tumor ablation trials.   In addition, he has numerous scientific abstracts and presentations at national and international society meetings. Locally, he is actively involved in many multi-disciplinary tumor boards and hospital committees.

Brad Wood is Chief of IR and founding Director of the NIH Center for Interventional Oncology , that develops and translates devices, software, and navigation approaches for cancer patients within a multi-disciplinary team, via public-private academic partnerships.  He leads a team of productive smart friends, partners, colleagues, and trainees. With > 50 patents, > 600 publications, H-index 98  including JAMA, NEJM, Nature Med, Science, Lancet, & Nature Comm.

Gloria L. Hwang, MD, FSIR

Gloria L. Hwang, MD, FSIR, is Clinical Professor of Radiology at Stanford. Her clinical interests include interventional oncology, portal hypertension, and biliary interventions. She also serves as the Associate Chair of Clinical Performance Improvement, Associate Program Director for the Department of Radiology, and chairs the Radiology IT Operations Committee; in those roles, she leads projects and programs to support radiologists to perform at their best.

Peter Kennedy FRCR EBIR is currently the lead interventional radiologist in Belfast, Northern Ireland which offers a full range of IR procedures to the 2 million population of Northern Ireland.

His undergraduate degree in Cambridge was followed by clinical medical school in Oxford UK. His  radiology training was in Northern Ireland, supplemented by an IR fellowship under Prof Eric van Sonnenberg in UTMB Galveston. He began and still continues his consultant practice in Belfast since 1999. He has served as President of the Irish Society of Interventional Radiology and now for the IOUK Committee in the UK. His main interest over the number of years has been treatments for HCC and colorectal cancer, particularly ablation and SIRT.

Bulent Arslan, MD, FSIR, earned his medical degree at Marmara University in Istanbul, Turkey. He completed a residency in diagnostic radiology and a fellowship in vascular and interventional radiology at University of Rochester Medical Center, NY. Before joining Rush in 2012, he served as Associate Professor of Radiology & Interdisciplinary Oncology at University of South Florida College of Medicine, Tampa. Previously, he served as Assistant Professor of Radiology at University of Virginia Health System, Charlottesville, and at University of Arizona, Tucson. He obtained his full professorship in Diagnostic Radiology and Nuclear Medicine at Rush University Medical Center in 2018. He was fellowship program director between 2012 and 2014 at Rush and division director from 2012 to 2022. Currently he is serving as the Chair of newly established Vascular & Interventional Service Line.

Dr Arslan is certified by the ABR in Diagnostic Radiology with CAQ in Vascular & Interventional Radiology. His clinical interests include complex deep venous interventions, aortic and peripheral vascular interventions, aortic and visceral aneurysms and interventional oncology.

An active researcher, Dr. Arslan has participated in more than 30 clinical trials and has authored more than 50 peer-reviewed publications and over 200 scientific abstracts, as well as several book chapters. A frequent speaker, he has been an invited lecturer at more than 200 regional, national, and international medical conferences.

Dr. Arslan is a fellow and member of SIR and also a member of ARRS, RSNA, CIRSE, NANETS, ISNVD, and AMA.

He currently serves as a reviewer for the Journal of Vascular and Interventional Radiology, CardioVascular and Interventional Radiology, and Neurosurgery.

Dr. Nutting is internationally renowned for his image

guided liver cancer and embolization therapies. Practicing for more

than 25-years, he is best known for liver

cancer therapies, having performed more than 5,000

Y90 radioembolizations, bland and chemo-

embolization of liver tumors.

He is also an expert in prostate artery embolization

(PAE) having treated more than 600 patients over the last 10 years. He trained with the experts in Portugal and Brazil; and is nationally recognized for training other physicians

around the country. Dr Nutting has transitioned his hospital based practice to the office-based lab (OBL) over the last 3 years.

 Blake Brickey Jacks, M.D. 

9 Ridgeview Ct. Cell: 870-692-7883 

Little Rock, AR 72227 blakebjacks@gmail.com 

CURRENT POSITION 

CARTI Cancer Center, Little Rock, AR 

Interventional Radiologist 8/1/2022-present 

EDUCATION & HONORS 

Miami Cardiac & Vascular Institute, Miami, FL 

Independent Interventional Radiology Residency 7/1/2020-6/30/2022 

• • Chief Resident 2021-2022 

University of Arkansas for Medical Sciences, Little Rock, AR 

Diagnostic Radiology Residency 7/1/2016-6/30/2020 

• • Chief Resident 2018-2020 
• • Interventional Radiology Interest Group—Resident Advisor 2018-2019 
• • UAMS Resident Council 2018-2020 o UAMS Chief Resident Council 2018-2020 
• • Society of Interventional Radiology—Resident-in-Training Scholar 2018 
• • American Institute for Radiologic Pathology (AIRP) Course 9/10/2018-10/5/2018 
• • Charles K. Roberts Professionalism Award—voted by co-residents 2017 

Internship 7/1/2015-6/30/2016 

University of Arkansas for Medical Sciences, Little Rock, AR 

College of Medicine—M.D.—Honors in Research May 16th, 2015 

• • Barton Foundation Scholarship for academic achievement 2014 
• • Clinical Examination Honors – Introduction to Clinical Medicine II 2013 

SOCIETY MEMBERSHIPS & INVOLVEMENT 

• • Society of Interventional Radiology 2014-present o Resident-Fellow-Student (RFS) member 2018-present 
• • Radiological Society of North America 2013-present 
• • American Roentgen Ray Society (ARRS) 2017-present 
• • American Medical Association 2011-present 

STATE LICENSURE 

• • Arkansas (E-12730) – Active, Unrestricted Issued 11/8/2019 
• • Florida (ME 142675) – Active, Unrestricted Issued 9/25/2019 

PUBLICATIONS 

1. Atiq, S.O., Atiq, O.O., Atiq, M.O., Phillips, K.C., Jacks, B.B. et al. Am J Case Rep 2018; 19:1241-1244. doi: 10.12659/AJCR.910224. The Role of Immunotherapy and Radiation Therapy in Tumor Chemosensitivity in Advanced Head and Neck Cancer (PMID: 30333474) 

2. Wadhwa, V., Jacks, B.B., Dubey, D. et al. Cardiovasc Intervent Radiol (2017) 40: 957. doi:10.1007/s00270-017-1608-2. Smartphone Apps as a Source of Information About Interventional Radiology (PMID: 28197829) 

Robert Suh, M.D. is a Clinical Professor in the Department of Radiological Sciences at the Ronald Reagan UCLA Medical Center and the David Geffen School of Medicine at UCLA since 1998. Currently, Dr. Suh serves as the Director of Thoracic Interventional Services and as the first Vice Chair of Radiology Education at UCLA Medical Center since 2016.  Dr. Suh is the current and has been Program Director of the Diagnostic Radiology Residency since 2002.

Dr. Suh received his BS degree at University of California Riverside and his MD from the David Geffen School of Medicine at UCLA. Following an internship at the University of California Irvine and Long Beach Veterans Administration Medical Center, Dr. Suh completed his training in diagnostic radiology at Loma Linda University Medical Center, followed by fellowships in both vascular interventional radiology and thoracic imaging at Loma Linda University Medical Center and UCLA, respectively. Dr. Suh was the former Director of Thoracic Imaging and Intervention at Loma Linda University Medical Center and was the Acting Chief of Thoracic Imaging at UCLA Medical Center from 2006-2007.

Dr. Suh’s clinical practice for over 20 years centers on interpreting diagnostic imaging of the lung and performing image-guided procedures within the lung and chest cavity, which include precision lung biopsies for diagnosis and treatment selection to fully enable personalized medicine for patients and thermal ablation of lung tumors utilizing microwave energy and cryotherapy. He is part of UCLA’s faculty that have pioneered and developed the discipline of Interventional Oncology on national and international levels. The Thoracic Interventional Services at UCLA Radiology is one of the most experienced centers specializing in lung procedures in the country, and over the past two decades, Dr. Suh is an internationally recognized leader in lung thermal ablation.

Dr. Suh has focused his research efforts primarily on image-guided thermal ablation, high-dose rate brachytherapy, tissue retrieval, image-guided intratumoral drug delivery and gene profiling technologies in the treatment of pulmonary malignancies, focusing on not only lung cancer but cancer that spreads to the lungs.  His collaborative efforts occur with his colleagues within the Thoracic Imaging Research Core in diffuse lung disease, pulmonary nodule characterization and biopsy technology, and with corresponding subspecialty colleagues, in lung cancer. Over his career, Dr. Suh has moderated and given over 500 presentations at local, regional, national and international meetings, conferences and congresses.

Dr. Koethe received her medical degree from the Duke University School of Medicine, before completing her interventional radiology training at the Miami Cardiac & Vascular Institute. She is currently an Assistant Professor and Associate Director in Interventional Oncology in Portland, Oregon at the Dotter Department of Interventional Radiology at Oregon Health & Science University. She serves on multiple committees and panels for the Society of Interventional Radiology, the American College of Radiology, the Society of Interventional Oncology, and the American Board of Radiology.

Dr. Siddharth Padia is an Interventional Radiologist and Professor of Radiology at the David Geffen School of Medicine at UCLA. He is also director of Interventional Radiology at UCLA Santa Monica. His areas of clinical expertise and research interests include liver cancer, interventional oncology, vascular disease and portal hypertension.

Dr. Padia earned his medical degree from Johns Hopkins University School of Medicine. After completing his transitional internship at The University of Hawaii in Honolulu, Dr. Padia began his residency in diagnostic radiology at the Cleveland Clinic in Ohio and graduated as Chief Resident. After spending many years practicing interventional radiology at the University of Washington, Dr. Padia joined the faculty at UCLA in 2016.

Dr. Padia specializes in advanced minimally-invasive technologies to treat liver cancer by infusing highly radioactive particles (Yttrium-90) into the liver, and has treated over 800 patients with this therapy. Due to his expertise in this field, he is the primary author of the national treatment guidelines for Yttrium 90 radioembolization, and is a director of the national annual course to educate physicians on this therapy. Recently, he has helped develop novel treatments for patients suffering from knee arthritis, specifically genicular artery embolization. He has recently led and completed the largest US clinical trial to date for genicular artery embolization, and is embarking on multiple trials for embolization of joint pain.

Robert C. G. Martin, II, M.D. PhD, is The Sam and Lolita Weakley Endowed Chair in Surgical Oncology, The Director of the Division of Surgical Oncology, faculty member of the James Graham Brown Cancer Center, and a Professor in the Department of Surgery.  He was appointed to the University of Louisville in 2002 as an Assistant Professor and achieved Professor of Surgery in 2011.   Dr. Martin received his M.D. from the University of Louisville School of Medicine (1995) and his surgical oncology training and hepato-pancreatico-biliary training from Memorial Sloan-Kettering Cancer Center (2002), and his PhD from the Department of Pharmacology and Toxiciology (2008) at the University of Louisville School of Medicine.

Dr Martin has mentored over 30 medical students and masters’ students through both the summer research scholar program as well as medical students outside of that program who have shown a significant interest in surgical and oncology research.  He is an active participant in a number of teaching activities including ongoing lectures to the third year medical students, journal clubs for both the senior honor medical students as well as surgical oncology fellows and an active participant of the medical students’ education through their rotations.

He has completed over 15 prospective clinical trials and principle investigator of 1 Humanitarin Device Exemption (HDE), 2 Investigation New Drugs (IND), and 3 Investigational Device Exemption (IDE) trials. He has completed over 5 NIH funded grants and continue to maintain an active basic science laboratory.

Dr. Martin’s clinical interests are focused on the multi-disciplinary care and surgical management of patients with upper GI malignancies, including esophageal, gastric, duodenal, liver, biliary, and pancreatic cancers.

His Clinical Research Interests are focused in: – Hepatocellular Cancer, Metastatic Colorectal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Gastric Cancer, and Esophageal Cancer with specific trials in all of these disease.

 – His research focus is surgical quality of care, metastatic colon cancer management and genetic predispositions to upper GI malignancies.

– Dr. Martin’s basic science interest focuses on the translational research  – defined as animal model evaluation in esophageal, hepatocellular, and pancreatic cancers – for naturally occurring chemoprevention therapeutics, nanoparticle and gold particle targeted therapy, as well as optimal device evaluation.

– Dr. Martin hopes to translate his findings to improve the overall care of these patients.

– He has written more than 400 first or senior author peer review manuscripts and is currently the Principal Investigator of multiple clinical trials evaluating new technology in the Hepato-Pancreatico-Biliary patient.

https://www.ncbi.nlm.nih.gov/pubmed/?term=(Martin+RC)+and+(louisville)

To me, diversity means a variety of backgrounds, people and perspectives. In my experience, it can bring out better solutions that reach a wider audience, and make the our University, Department, and Division an atmosphere that is more welcoming. Equity means making sure that everyone has equal opportunities, compensation and voice in decision-making, which I think is important in hiring and during everyday operations. When we can make internal processes more equitable and fair, the Division/Department can truly build up the talent it has and can attract a wider range of future hires. Inclusivity is when we implement these values and help make sure that our diverse workforce feels safe, valued and welcomed.

Commitment to Diversity and Inclusion

1. I have been integral in hiring and increasing the diversity in my Division and Department of full time faculty (currently your Division is balanced) 
2. I have been integral in our commitment to increasing representation for or the Surgical Oncology Fellowship over the last 10 years
3. I have maintained a commitment to intentional inclusion through my mentoring of Students, Residents, Fellows, and Faculty

Flavio G. Rocha, MD, FACS, FSSO

Dr. Rocha is the Hugh and Georgeina Hedinger Chair of Surgical Oncology at Oregon Health and Science University (OHSU) in Portland, OR. He also serves as the Physician-in-Chief of the Knight Cancer Institute at OHSU. He graduated with honors from the University of Chicago Pritzker School of Medicine. After training in general surgery at the Brigham and Women’s Hospital and Harvard Medical School both in Boston, he completed both a surgical oncology and hepatopancreatobiliary surgery fellowship at Memorial Sloan-Kettering Cancer Center in New York.  Dr. Rocha’s clinical practice encompasses all aspects of benign and malignant disease of the liver, bile ducts and pancreas. He has been funded by the AAS, NIH/NIDDK, ASCO and the Cholangiocarcinoma Foundation. Dr. Rocha currently sits on the editorial boards of Surgery, HPB, Annals of Surgical Oncology, and Journal of Surgical Oncology. He has served on the NCI Pancreas Task Force, ASCO Gastrointestinal Cancers Advisory Council and ASTRO Liver Cancer Guidelines Committee.  He is currently the surgical lead of the International Cholangiocarcinoma Research Network (ICRN), Vice-Chair of the Southwest Oncology Group (SWOG) Surgery Committee, GI Surgery Working Group Chair at Eastern Cooperative Group (ECOG-ACRIN) and Secretary/Treasurer of the North Pacific Surgical Association.

Matthew S Johnson, MD, FSIR

Director of Clinical Research, Department of Radiology & Imaging Sciences

Global Health Liaison, Department of Radiology & Imaging Sciences

Director of Interventional Oncology

Gary J Becker Professor of Radiology Research

Professor of Radiology and Imaging Sciences and Surgery

Indiana University School of Medicine

Jean-Francois (Jeff) H. Geschwind, MD, is currently the Director of Oncology at USA Clinics Group; the Medical Director for Oncology and Image-Guided Therapy at Syntactx/NAMSA, a contract research organization based in New York City; Medical Director for Imaging, Clinical and Scientific Affairs, Imaging Endpoints, LLC, a contract research organization specialized in cancer imaging; and a consultant for Cage Pharma, previously PreScience Labs, a company he founded in 2009 which is focused on developing cancer drugs targeting tumor metabolism, specifically glycolysis.  He is also a scientific consultant for Philips Healthcare advising them on all matters related to oncology and image-guided therapy.

Dr. Geschwind earned his Medical Degree from Boston University School of Medicine, completed his residency training in Diagnostic Radiology at the University of California at San Francisco as a Resident-Scholar sponsored by the National Institutes of Health (NIH) and his fellowship training in Vascular and Interventional Radiology at the Johns Hopkins University School of Medicine.  He is the former Director of the Division of Vascular and Interventional Radiology at the Johns Hopkins University School of Medicine and Chairman of Radiology and Biomedical Imaging at Yale School of Medicine.

Dr. Geschwind has published almost 300 scientific manuscripts (Google Scholar H-Index 75), wrote the first textbook dedicated to Interventional Oncology, co-edited the textbook of reference in Interventional Radiology, namely, Abram’s Angiography, and was the lead or co-investigator on more than 50 clinical trials testing innovative treatments for patients with liver cancer. Dr. Geschwind is recognized internationally as an expert and key opinion leader in liver cancer.

Dr. Geschwind has received numerous national and international awards throughout his career including among others, the Annual Memorial Award from the Association of University Radiologists, the Alexander Margulis Award for Excellence in Research, the Society of Interventional Radiology Gary Becker Young Investigator Award, the American Society of Clinical Oncology Merit Award, the American Roentgen Ray Society Fellowship Award, the Boston University School of Medicine and the University of California San Francisco Department of Radiology Alumni Award, the Ernest Ring Academic Development Program from the Society of Interventional Radiology and the Wilhelm Conrad Roentgen Honorary Award from the European Society of Radiology.  In 2012, he was inducted into the Academy of Radiology Research from the Radiology Society of North America, the highest recognition for radiologists.

Dr. Geschwind was visiting professor and has given numerous lectures and keynote speeches including named lectures at various prestigious institutions such as (among others) the NIH, Memorial Sloan Kettering Cancer Center, University of Pennsylvania, MD Anderson Cancer Center, the University of Michigan, Georgetown University, Brown University, Yonsei University, Seoul National University, Malaysia Cancer Center, and the Chinese University of Hong Kong.  Dr. Geschwind has also been recognized as a Top Doctor by US News and World Report.

Keith Quencer M.D. is an interventional radiologist at OHSU with particular interest in GU interventions including renal ablation, adrenal vein sampling and dialysis interventions.

Dr. Abi-Jaoudeh is an American and Canadian board-certified vascular and interventional radiologist at the University of California Irvine. Dr. Abi-Jaoudeh earned her medical degree from the University of Montreal and completed internship and residency at the University of Laval in Québec, Canada a fellowship in interventional radiology at the University of Virginia in Charlottesville, Va. She then joined National Institutes of Health where she was a principal and associate investigator on several human trials. She also completed multiple animal and translational studies. In 2015, Dr. Abi-Jaoudeh joined the University of California Irvine where she has grown the research program. In 2018, she became the director of Clinical research of the department of Radiology and in 2020 she became section chief of interventional radiology. She is principal investigator on multiple Phase I, II and III trials.

Her clinical interests include minimally invasive image guided interventions, including but not limited to, vascular and non-vascular oncological interventions.

Her research interests include fusion and functional imaging during image guided procedures, innovative therapeutic methods to treat metastatic and primary liver disease. Her goal is to grow a translational research program to improve UCI patient care and outcome

Dr Abi-Jaoudeh is a fellow of the Society of Interventional Radiology, a member of the Royal Canadian College of Radiology. . Dr Abi-Jaoudeh is a member of the annual meeting committee of the SIR and will be the chair of the meeting in 2022. She is deputy editor of JVIR. She is the division chair of the clinical and registries committees of the SIR Foundation.

Alan Alper Sag, MD is Assistant Professor and Interventional Radiologist at Duke University Medical Center. He is a member of the and Duke Cancer Institute Spine Metastasis Team, Orthopedic Oncology Bone Metastasis Team, and Duke Cancer Institute Endocrine Neoplasia Team. He concentrates on augmentation, ablation, and embolization for vertebral fractures and bone metastases as well as goiter embolization, thyroid RFA and cryoablation of locally recurrent thyroid cancer.

Robert J. Lewandowski, M.D., FSIR, is a Professor of Radiology, Medicine, and Surgery in the Feinberg School of Medicine at Northwestern University. He serves as the Director of Interventional Oncology at the Northwestern University Robert H. Lurie Comprehensive Cancer Center. Dr. Lewandowski joined the staff at Northwestern in 2006 upon completion of his fellowship training in Vascular and Interventional Radiology. Dr. Lewandowski is a practicing interventional radiologist who specializes in liver-directed therapy. Based on his clinical oncology program, he has authored or co-authored > 150 articles for peer-reviewed journals on the application of liver-directed therapies for patients with gastrointestinal malignancies. Dr. Lewandowski also performs pre-clinical oncology research in the Northwestern University Interventional Oncology Laboratory and Center for Translational Imaging. In this capacity, he is developing and evaluating novel oncology therapeutics, delivery mechanisms, and imaging modalities. Dr. Lewandowski’s work has been supported by the National Institute of Health, American Cancer Society, the Society of Interventional Radiology Foundation, and through industry collaboration via the investigator-initiated trial mechanism.

Luigi Alessandro Solbiati was born in Busto Arsizio (Milan area) in 1952, graduated cum laude from the University of Milan in 1977 and received his postgraduate degree in Radiology from the School of Radiology of Milan University in 1981.  He was resident at the Department of Ultrasound of the Royal Marsden Hospital in Sutton (UK) with Prof. Davide Cosgrove in 1981 and at the Department of Medical Physics of the Hospital of Bristol (UK) in 1982.  In his clinical activity, he had been working for 35 years at the General Hospital of Busto Arsizio, from the initial role of Assistant to that of Chairman of the Department of Diagnostic Imaging (2002-2011) and Oncology (2012-2015) and Head of the Division of Interventional Oncologic Radiology (2010-2015).

In his academic career, since 1988 he had been appointed as Contract Professor of “Techniques and Methods of Diagnostic Imaging” at the School of Radiology of the University of Milan. In 2014 he received the Academic Qualification of Full Professor of Radiology. In 2015 he moved to Humanitas University at Pieve Emanuele (Milan) and Humanitas Research Hospital at Rozzano (Milan), where he is currently Professor of Radiology and Consultant of Interventional Radiology, respectively. 

He was Board Member of the Italian Society of Ultrasound in Medicine and Biology (1985-1991), President of the Section of Ultrasound of the Italian Society of Radiology (SIRM) (2006-2010), Member of the Executive Council of European Society of Radiology (ESR) (2008-2010) and Vice-President of SIRM (2008-2010).

His main fields of interest have always been interventional procedures in oncologic and non-oncologic diseases (particularly percutaneous image-guided thermal ablation), imaging of the neck, sonography and contrast enhanced sonography.  After being one of the pioneers of ultrasound-guided aspiration biopsies (1979), in 1982 he performed what is considered the very first ablation ever performed, i.e. the ultrasound-guided percutaneous ethanol injection (PEI) of a large inoperable parathyroid adenoma. He was the pioneer of PEI of HCCs (1985) and radiofrequency ablation (RFA) with cool-tip electrodes of HCCs and liver metastases (1995), together with the group of Dr. Tito Livraghi (Hospital of Vimercate, Milan area). Subsequently he was one of the first users in the world of high-power microwave ablation (MWA) of solid tumors (2009) and of image fusion of real-time US with CT, MRI and PET for the guidance of interventional procedures (2003).

With his team he has one of the largest experiences in the world in RFA and MWA of liver malignancies and renal cell carcinomas, but also in laser and RF ablation of thyroid and parathyroid benign tumors, accounting for more than 6,000 patients treated.

In 2018 he was the first clinical user worldwide of a novel independent software platform for volumetric assessment of ablation completeness (ablation confirmation), and in 2019 he was the first clinical user of a platform of augmented reality for the guidance of thermal ablations of liver malignancies.

Research and Publications

He published 190 original articles in peer-reviewed journals as of yet, 161 of them indexed in PubMed.

His Google-scholar H-index is currently 68, his i-10 index is 137, the impact factor by far exceeds 450 and his publications had 29,324 citations (Google Scholar). He holds the 2nd place in the world ranking of the Authors of the 100 papers of international radiological literature published between 1945 and 2012 with the largest number of citations (American Journal of Roentgenology 2013; 201: 471-481).

In addition, he published 62 chapters in textbooks of Radiology, Interventional Radiology and Oncology,

and was Editor and Author of 12 books on small-parts sonography, contrast-enhanced sonography and ablative therapies, 5 of them for international publishers in English.

He gave 642 presentations at Meetings, Congresses and Courses in 23 different countries and was

Invited Speaker at 245 International Congresses and Courses.  He was Guest Lecturer at the Universities of San Diego, Zurich, Beijing, Hong Kong, New Delhi, Cairo, Vienna, Moscow, Chelyabinsk (Russia), Madison (USA), Guangzhou (China), and at the Mayo Clinic, Rochester (USA).

In 2006 he was the Chairman of the 1^st World Conference on Interventional Oncology in Cernobbio (Lake Como).

Graham Munneke is a consultant interventional radiologist at University College London Hospitals.  He qualified from St George’s Hospital Medical School and after gaining membership to the Royal College of Physicians and Fellowship of the Royal College of Radiologists he subsequently subspecialised in Interventional Radiology.

Graham is the past chairman of the research and registries committee of the British Society of Interventional Radiology.  He currently sits on the management committee of the European CIRT registry looking at patients treated with radio-embolisation across Europe.  He has been a   special advisor to NICE for radio-embolisation and was a member of the NHS England Commissioning through evaluation SIRT committee.

Graham is the author of several peer-reviewed papers and has lectured at National and International level on targeted oncological therapies.

Prof. Dr. Tze Min Wah
MSc (Birmingham, UK), PhD (Leeds, UK)
MB ChB (Leeds, UK), FRCR (UK), CCST (UK), , EBIR (CIRSE), FHEA (UK), Pg. Cert. Clin. Ed. (Leeds, UK)

Prof. Tze Min Wah is a senior consultant interventional radiologist with specialist interest in both imaging and interventional oncology (IO) treatments with strong academic interest in promoting IO research as well as education/training in IO. Since 2003, she has led and developed the IO programme at the Leeds Teaching Hospitals Trust (LTHT) using various technologies e.g. radiofrequency (RFA), microwave ablation (MWA), cryoablation (CRYO) and irreversible electroporation (IRE) for a range of cancers. Today, Leeds is one of the leading national and international IO centres with reputable clinical outcomes especially with world class outcome in renal cancer treatment. She is recognised as a trail-blazer in translating innovative technology in cancer treatment and a key opinion leader in the field of IO.

She is a Professor of Interventional Radiology at Leeds Institute of Medical Research (University of Leeds). In addition, she holds many academic appointments from honorary professorship in Malaysia and visiting professorship in Singapore. She has a vibrant research portfolio with successful funding of £ 4.8 million (£1.92 million as Chief Investigator). She is the Chief Investigator for #Hope4Liver- (https://clinicaltrials.gov/ct2/show/NCT04573881) in United Kingdom and in 2021 led the successful translation of the image guided Histotripsy treatment in liver cancer patients in UK https://www.nationalhealthexecutive.com/articles/uk-patients-liver-cancer-NHS-ultrasound-technology

She is a keen educator and lectured extensively on IO related topic in order to help to promote awareness and providing mentoring schemes to many trainees and consultants in IO on national and international levels since 2003. Being awarded the RCR BSIR Graham Plant Travelling Professorship in 2019-2022 has allowed her to lecture a trainees across the disciplines to promote IO as one of the important pillar of cancer care during the pandemic period.

In addition, she is a passionate champion for Equality, Diversity and Inclusion and love to inspire more women into Interventional Radiology (IR). She has strived to inspire all male and female IRs to help in closing the IR gender gap issue in Europe as evidenced by her published work on –

The Interventional Radiology (IR) Gender Gap: A Prospective Online Survey by the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) https://www.ncbi.nlm.nih.gov/pubmed/29789874. In 2021, she is also the invited panellist for the Women Leader in Academic Research (WLAR) led by Prof Brad Wood at National Institute of Health (NIH) to promote women in academia.

I did my graduation from Maulana Azad Medical, New Delhi in 1993 and my postgraduation in Radiodiagnosis from the same institute in 1998. Subsequently I did my three-year senior residency from PGIMER, Chandigarh. I am working as a faculty member in the Department of Radiodiagnosis at PGIMER since October, 2001 and as Professor since July, 2014. I am pursuing an academic career and have been actively involved in clinical and research work for the past twenty years. My area of interest is gastrointestinal radiology with focus on interventional oncology related to hepatobiliary interventions. I have 180 PubMed indexed publications and 29 book chapters to my credit. I have made 115 presentations and have delivered 181 guest lectures. I have been chief guide and co-guide of several theses of MD, MS, DM, MCh and PhD students. I have completed several research projects including those funded by ICMR, SERB (DST) and RSNA (Radiological Society of North America). I am reviewer of many journals including the prestigious American Journal of Roentgenology and Associate Editor of the official journal of Indian Society of Vascular and Interventional Radiology (ISVIR), Journal of Clinical Interventional Radiology.

Professor Thierry Jacques De Baère, is head of the Interventional Radiology Unit at Institut Gustave Roussy Cancer Center in Villejuif, France, where he has worked since 1991. Gustave Roussy is the margest european cancer center. His clinical work is dedicated to minimal invasive therapy for treatment of liver, lung, and kidney tumors, including intra-arterial therapies for primary and secondary liver tumors, percutaneous ablation of liver tumors and lung tumor including radiofrequency and cryoabalation.  He and his team have also investigated preoperative portal vein embolization in order to hypertrophy unembolized parts of the liver, as well as SIRT. IO4IO (interventional radiology for Immuno-oncology) is part of his new very cative research fields. Many treatments, today in clinical routine, have been developed from experimental studies in order to allow a rapid transfer from bench-top to clinical applications. He is the author of 280 peer-reviewed articles and over 350 scientific communications, reveiwer for many cancer and interventional radiology journals, and section chief editor for oncology section in cardiovascular interventional radiology Journal. Member of CIRSE and ESMO. He isinvolved in many international guideliens on HCC, Colorectal Cancer, lung metastases. He is principal Investigator of several international studies on ablation, intraarterial therapies, combined therapies and other innovative locoregional treatments.

Dr. Deepashree is an Interventional Radiologist, based in Chennai having 10+ years of experience.

Her expertise lies in the management of non-surgical trauma, embolization in bleeding cases, ablation, minimally invasive injections, male and female infertility, uterine fibroid non-surgical treatments, non-surgical treatment of varicose veins, prostate hypertrophy, leg ulcers, etc, Chemotherapy lines and port insertions by a minimally invasive approach, FNAC’s, Biopsies and drainages.

Dr. Deepashree was chosen as an international scholar to represent India in 2015 at the Society of Interventional Radiology Meeting, Atlanta, USA. She is a member of the Royal College of Physicians, UK, and European Board of Interventional Radiology.

Function: Resident Interventional Radiology

Affiliation: Department of Radiology and Nuclear Medicine, Amsterdam UMC & OLVG Hospital, Amsterdam, the Netherlands

Expertise: Computed Tomography, Magnetic Resonance, Angiography, Interventional Radiology, Abdominal Radiology, Primary and secondary liver malignancies, Pancreatic Diseases, Biliary Tract Diseases, Cholangiocarcinoma, microwave ablation, radiofrequency ablation, irreversible electroporation, time-to-event end points in Image-guided Tumor Ablation.

Overview:

A specialist in Radiology with a rich experience of over 15 years is currently working in Manipal Hospital, Old Airport Road. The Doctor has expertise in Interventional Oncology – TACE, SIRT, Microwave Ablation, Fibroid Embolisation, Uterine artery Embolisation for PPH, Hepato-Biliary Interventions – PTBD and Biliary stenting, Gastro-Intestinal Interventions – TIPSS, BRTO, Haemo-Dialysis Access, Fistula Intervention, Complex central vein recanalization, Urological Interventions – Ureteric stenting, Varicocoele embolization, Nephrostomy, Ultrasound, and CT-Guided biopsy and drainage, Peripheral Vascular Interventions- Angioplasty, Stenting, Endovascular Aneurysm Repair for Aortic aneurysm, Musculoskeletal Interventions, Emergency embolization for bleeding. The Doctor got Gold Medal in General Surgery (Sri Devaraj Urs Medical College) and also got the highest overall marks in Final MBBS. He has handled numerous complex medical cases and is known for attention to detail, accurate diagnosis, and treating patients with empathy.

Dr Heithaus is an Interventional Radiologist at the University of Florida Shands Hospital in Gainesville Florida.  He is the associate division chief and the head of IR research at UF.  Dr Heithaus is the head of the UF IRE program and is the site PI for the Direct Trial.

Specialties & Experience

General Specialties:

 Interventional & Vascular Radiology and Radiology

Specialty Focus:

 IVC filter, DVT, Pulmonary Embolism, blood clot, TIPS, AVM, embolization, Y90, TACE, IRE, nanoknife, cryoablation, microwave ablation, stents, dialysis procedures, biliary and urinary interventions, vertebroplasty/ kyphoplasty, endovascular procedures, biopsy, drainage, CT, MRI, Ultrasound, PET scan

Education:

 MD, University of Florida

Years in Practice:

 3

Additional Information

I am a dual board certified and fellowship trained Vascular and Interventional Radiologist. I am a clinical assistant professor at the University of Florida. I have experience in private practice prior to academic practice. I also have prior expert witness experience. I currently work at a large Level 1 trauma center, and my hospital is also a regional liver and kidney transplant center. I have a large experience with TIPS and cirrhosis / portal hypertension. I also have experience with liver transplant complications. A portion of my practice is devoted to treating DVT and PE. I perform DVT thrombectomy and IVC filter placement and retrieval. I have experience with complex IVC filter retrieval including removal of IVC filters protruding into the aorta (artery), bowel, and spine. I have removed “permanent” filters as well as fragmented/broken filters. I have experience with thrombolysis for DVT/PE. I also perform endovascular reconstruction of occluded veins including stenting. I have a strong interventional oncology practice, and I perform ablations including IRE (irreversible electroporation, aka “nanoknife”), cryoablation, microwave ablation, and bone RFA ablation. I regularly treat patients with rare sarcomas. I perform Y90 radioembolization (selective internal radiation therapy), TACE (transarterial chemoembolization), and bland embolization. I treat a number of cancers including hepatocellular carcinoma, cholangiocarcinoma, metastatic colorectal cancer, neuroendocrine metastasis, lung cancer, pancreatic cancer, breast cancer, prostate cancer, and other rare cancers. I place ports for chemotherapy. I perform embolization and sclerotherapy of AVMs (arterial venous malformations), low flow venous malformations, venolymphatic malformations, hemangiomas, etc. I continue to practice diagnostic radiology as well, and I regularly interpret radiology exams including xray, ultrasound, MRI, and CT. I have experience with PET/CT with my oncology patients.

• Request Free Print Directory

Thomas Scagnelli, M.D. joined Miami Vascular Specialists in 2009 after having served as an Associate Professor of Interventional Radiology at the University of Florida College of Medicine, and prior to that, at the University Of Miami School Of Medicine, where he was involved in the training of numerous resident physicians and fellows in Vascular and Interventional Radiology. He presently serves as a Voluntary Associate Professor of Interventional Radiology at the University Of Miami School Of Medicine. He is currently the Medical Director of Interventional Radiology and the Associate Director of Diagnostic Radiology at Doctor’s Hospital, Baptist Health South Florida in Coral Gables, Florida.

Dr. Scagnelli is a native of Brooklyn, New York having attended Xaverian High School in Bayridge Brooklyn and Rutgers University in New Brunswick, New Jersey. He received his Medical Degree from CETEC University School of Medicine in Santo Domingo. He completed an Internship in Internal Medicine and a combined residency in Diagnostic Radiology and Nuclear Medicine at the Long Island College Hospital in Brooklyn, New York and a fellowship in Vascular and Interventional Radiology at the University Of Miami School Of Medicine.

Dr. Scagnelli serves as a board examiner for the American Board of Radiology (ABR) for both the Board Examinations in Diagnostic Radiology and Vascular and Interventional Radiology. He is a member of the Society of Interventional Radiology (SIR) and serves on the SIR membership committee. He is also a member of the Radiological Society of North America (RSNA), for which he has monitored many scientific sessions at its annual meeting, and is also a member of the American College of Radiology (ACR). He also serves as a member of, and advisor to, the Vascular and Interventional Examination Committee for the American Registry of Radiologic Technologists (ARRT).

Dr. Scagnelli has participated in multiple clinical research projects involving inferior vena cava filters, transarterial chemoembolization procedures, endovascular repair of arterial trauma, transhepatic portosystemic shunt procedures in treatment of intractable ascites, and transjejunal and conventional biliary tract intervention.

Dr. Scagnelli is Board-certified in Diagnostic Radiology with a Certificate of Added Qualification in Vascular and Interventional Radiology from the American Board of Radiology (ABR).

Dr Shuvro H Roy-Choudhury, FRCS (London), FRCR (London), CCST (UK), FCIRSE, EBIR is a Consultant in Diagnostic and Interventional Radiology who works in India and part time in the UK with over 25 years of experience in the UK.

Professional Qualifications:

After completing his surgical training and FRCS, he trained in Radiology in Yorkshire before completing a Fellowship in Interventional Radiology in Guy’s and St Thomas Hospital in London under the supervision of Professor Andreas Adam, ex President of the Royal College of Radiologists. He has worked with stalwarts in Interventional Radiology like Dr Riccardo Lencioni in Italy, Dr T DeBaere and Dr Afshin Gangi in France. He is one of the first European Interventionists to be awarded the European Board and Fellowship. He has worked as a senior Consultant in a leading teaching hospital in the UK since 2004 and as a lead in Interventional Radiology in NH group of Hospitals, Kolkata since 2014.

Expertise and roles:

He practises the breadth of Abdominal, Cardiovascular & Interventional Radiology with particular expertise in tumour ablations like RFA, embolisations including fibroids and prostate, complex needle biopsies, injections and drainages, biliary and urological stents, bone intervention, peripheral arterial and venous interventions including varicose veins, dialysis fistula, TIPSS etc. Since a sabbatical in India in 2012, he has successfully set up the first dedicated interventional lab and a comprehensive team in Eastern India. This lab is credited with several firsts in the region and performs complex interventions including aortic surgeries, complex below knee angioplasties, often in close cooperation with other clinical specialities. He is also an expert in thoraco-abdominal CT and MRI including the use of 320 slice CT, bariatric radiology, staging of cancers and is a US level II certified interpreter of cardiac CT and currently offers a second opinion imaging service on these topics.
Active in research and teaching, Dr Roy-Choudhury has 39 peer-reviewed publications, over 105 international scientific presentations, over 120 invited lectures and has contributed chapters in 6 textbooks. He set up and ran the first tumour ablation service (lung, kidney and liver) in the Midlands (UK) and was the author of the first European paper on kidney ablation. Research areas include tumour ablation, dialysis access, fibroid embolisations, rectal cancer, perianal fistulae, GI bleeding, CT Colonography, laparoscopic banding for obesity, abdominal trauma, biliary/enteral stents, pelvic floor imaging etc. He lectures widely and is an invited faculty in several British (ACPGBI, BSIR), Indian (ISVIR, IRIA, TTRI, ARSCICON, IACTI, APICON, USICON, EMCON, NEW, EVL, PULMOCON), European (ESGAR, CIRSE, ECIO), Asia-Pacific (APCIO, APSCVIR, CCMA) and American (SIR, SPECTRUM) meetings and serves as a reviewer of several European & Indian journals.

He is currently the President Elect of the Indian Society of Vascular and Interventional Radiology and the Vice President of the Indian Society of Interventional Onco-Radiology. He is a proctor for tumour ablation in India and the UK and is on the advisory board for several medical organisations. He was awarded the ‘Hero’ in IR in Eastern India by ISVIR for changing the landscape of IR in this part of India. He was the only international interventional radiologist on a WHO team preparing an international document on kit and staffing for hospitals in cancer management. He is often in the news, mostly credited with several ‘firsts’ in Eastern India, including kidney ablation, trauma embolisation, fertility following fibroid embolisation, TEVAR etc

Current appointment:

He currently leads Interventional & Endovascular Radiology and Specialised Imaging for a large private hospital with 7 sites in Eastern India (NH Group) and works part time as a Consultant Radiologist at University Hospital of North Midlands at Stoke-On-Trent, UK. He can be contacted via email at imagingandintervention@gmail.com, via the switchboard at NH Kolkata at +91 33 71222222, via mobile at +918337066672, or, when in the UK, at, +447407204629.

Mark Emberton is Professor of Intervention Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London.  He is clinically active and holds the position of Honorary Consultant Urologist at University College London Hospitals NHS Trust where he works as a specialist in prostate cancer.

His academic work has focused on developing novel diagnostic strategies and new therapies for men with prostate cancer.  His research has resulted in the transformation of both the diagnostic and therapeutic pathways.  These have been incorporated into international guidelines.

He has published over 500 peer review papers, holds a large grant portfolio, and lectures widely around the world and holds international honorary professorships.

He is a founding Pioneer of the charity Prostate Cancer UK.

PRESENT TITLE & AFFILIATION:

               Clinical Associate Professor

               Department of Radiology

               Seoul National University Hospital

               Department of Radiology

               Seoul National University Hospital

               101, Daehak-ro, Chongno-gu, Seoul 03080, Korea

LICENSURES:

              National Medical License, Korea (#86122) – January 2005

EDUCATION

UNDERGRADUATE  :             College of Liberal Arts and Science

                                                    Seoul National University

                                                    (March 1999-February 2001)

GRADUATE         :                   College of Medicine – M.D.

                           Seoul National University

                                                    (March 2001 – February 2005)

                                                    Graduate School – M.S.

                                                  Seoul National University

                                                  (March 2008 – February 2014)

                                   Graduate School – Ph.D.

 Seoul National University

                                                  (March 2014 – August 2017)

POSTGRDUATE     :                Rotating Internship

                                                    Seoul National University Hospital, Seoul

                           (March 2005 – February 2006)

                           Radiology Residency

                           Seoul National University Hospital, Seoul

                           (March 2006 – February 2010)

                           Radiology Fellowship

                           Seoul National University Hospital, Seoul

                           (April 2013 – February 2014)

SPECIALTY BOARDS  :         Korean Board of Radiology (#2702) (February 2010)

ACADEMIC & PROFESSIONAL APPOINTMENTS: 

    Clinical Assistant Professor of Radiology

        Seoul National University Hospital

        (March 2014- August 2017)

    Clinical Associate Professor of Radiology

        Seoul National University Hospital

        (September 2017- )

MEMBERSHIP

National

  Korean Radiological Society (2010-     )

  Korean Society of Medical Ultrasound (2013-     )

  Korean Society of abdominal radiology (2013-     )

       International

          European Society of Radiology (2016-      )

          Radiologic Society of North America (2017-    )

Award

          Best scientific paper award in 2016 KSR

      Participation in Clinical Trial

Radiofrequency Ablation Using Octopus Electrodes for small hepatocellular carcinoma with no-touch technique: A Prospective multicenter Study (PI: Jeong Min Lee)

Radiofrequency Ablation Using Octopus Electrodes for small hepatocellular carcinoma with no-touch technique: a Preliminary Study (PI: Jeong Min Lee)

AI-based CT reconstruction using ClariCT software for noise reduction and improvement of image quality of Contrast enhanced liver CT: A prospective multinational multicenter single arm study (PI: Jeong Min Lee)

Scientific Paper Publication

SCI Corresponding Author

1. Kang HJ, Lee DH, Park SJ. & Han JK. Virtual noncontrast images derived from dual-energy CT for assessment of hepatic steatosis in living liver donors. European Journal of Radiology 2021. 139, 109687.
2. Bae, J. S., Lee, D. H., Yoo, J., Yi, N. J., Lee, K. W., Suh, K. S., Kim, H. & Lee, K. B. Association between spleen volume and the post-hepatectomy liver failure and overall survival of patients with hepatocellular carcinoma after resection. Eur Radiol 2021 Apr;31(4):2461-2471
3. Kang HJ, Kim H, Lee DH, Hur BY, Hwang YJ, Suh KS, Han JK. Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery. 2021 Sep;300(3):572-582.
4. Yoo J, Min JH, Lee DH, Hur BY, Kim SW, Kim E. Abbreviated Magnetic Resonance Imaging With Breath-Hold Three-Dimensional Magnetic Resonance Cholangiopancreatography: Assessment of Malignant Risk of Pancreatic Intraductal Papillary Mucinous Neoplasm. J Magn Reson Imaging. 2021 Oct;54(4):1177-1186
5. Jeon SK, Lee DH, Park J, Suh KS, Yi NJ, Hong SK, Han JK. Tumor volume measured using MR volumetry as a predictor of prognosis after surgical resection of single hepatocellular carcinoma. Eur J Radiol. 2021 Nov;144:109962.
6. Park, S. J., Lee, D. H. & Han, J. K. Reducing Pain by Artificial Ascites Infusion During Radiofrequency Ablation for Subcapsular Hepatocellular Carcinoma. CardioVascular and Interventional Radiology. 2021; 44(4): 565-573
7. Yoo, J., Kim, S. W., Lee, D. H., Bae, J. S. & Cho, E. J. Prognostic role of spleen volume measurement using computed tomography in patients with compensated chronic liver disease from hepatitis B viral infection. European Radiology. 2021; 31(3): 1432-1442
8. Park, S. J., Jang, S., Han, J. K., Kim, H., Kwon, W., Jang, J. Y., Lee, K. B., Kim, H. & Lee, D. H. Preoperative assessment of the resectability of pancreatic ductal adenocarcinoma on CT according to the NCCN Guidelines focusing on SMA/SMV branch invasion. Eur Radiol. 2021 Sep;31(9):6889-6897
9. Kang, H. J., Lee, D. H., Lee, J. M., Yoo, J., Weiland, E., Kim, E. J. & Son, Y. Clinical Feasibility of Abbreviated Magnetic Resonance with Breath-Hold 3-Dimensional Magnetic Resonance Cholangiopancreatography for Surveillance of Pancreatic Intraductal Papillary Mucinous Neoplasm. Investigative Radiology. 2020 May; 55(5): 262-269
10. Yoo, J., Lee, M. W., Lee, D. H., Lee, J. H. & Han, J. K. Evaluation of a serum tumour marker-based recurrence prediction model after radiofrequency ablation for hepatocellular carcinoma. Liver International. 2020 May; 40(5): 1189-1200
11. Bae, J. S., Lee, D. H., Lee, J. Y., Kim, H., Yu, S. J., Lee, J-H., Cho, E. J., Lee, Y. B., Han, J. K. & Choi, B. I. Quantitative Assessment of Fatty Liver using Ultrasound with Normalized Local Variance Technique. 22 Apr 2020, (E-pub ahead of print) In: Ultraschall in der Medizin (Stuttgart, Germany: 1980).
12. Bae, J. S., Lee, D. H., Lee, J. Y., Kim, H., Yu, S. J., Lee, J. H., Cho, E. J., Lee, Y. B., Han, J. K. & Choi, B. I. Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique. European Radiology. 2019 Dec; 29(12): 6499-6507
13. Bae, J. S., Lee, D. H., Joo, I., Jeon, S. K. & Han, J. K. Utilization of virtual non-contrast images derived from dual-energy CT in evaluation of biliary stone disease: Virtual non-contrast image can replace true non-contrast image regarding biliary stone detection. European Journal of Radiology. 2019 Jul; 116: 34-40

SCI First Author

1. Lee DH, Cho, E. J., Bae, J. S., Lee, J. Y., Yu, S. J., Kim, H., Lee, K. B., Han, J. K. & Choi, B. I. Accuracy of Two-Dimensional Shear Wave Elastography and Attenuation Imaging for Evaluation of Patients With Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol . 2021 Apr;19(4):797-805.e7 co-first
2. Lee DH. Quantitative assessment of fatty liver using ultrasound attenuation imaging. J Med Ultrason (2021). 2021 Oct;48(4):465-470.  Review
3. Lee DH, Kim B, Lee ES, Kim HJ, Min JH, Lee JM, Choi MH, Seo N, Choi SH, Kim SH, Lee SS, Park YS, Chung YE; Korean Society of Abdominal Radiology. Radiologic Evaluation and Structured Reporting Form for Extrahepatic Bile Duct Cancer: 2019 Consensus Recommendations from the Korean Society of Abdominal Radiology. Korean J Radiol. 2021 Jan;22(1):41-62.  Review
4. Lee DH, Lee MW, Kim PN, Lee YJ, Park HS, Lee JM. Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial. 2021 Oct;301(1):229-236. Co-first
5. Lee DH, Lee ES, Bae JS, Lee JY, Han JK, Yi NJ, Lee KW, Suh KS, Kim H, Lee KB, Choi BI. 2D shear wave elastography is better than transient elastography in predicting post-hepatectomy complication after resection. Eur Radiol. 2021 Aug;31(8):5802-5811 co-first
6. Lee, D. H., Lee, J. Y., Joo, I., Kim, T. Y., Han, S. W. & Lee, K. H. Shear-wave velocity for colorectal cancer liver metastases as a potential prognostic factor after chemotherapy: a preliminary study. Clinical Radiology. 2021 March; 76(3): 224-232 9
7. Lee, D. H., Kim, J. W., Lee, J. M., Kim, J. M., Lee, M. W., Rhim, H., Hur, Y. H. & Suh, K. S. Laparoscopic Liver Resection versus Percutaneous Radiofrequency Ablation for Small Single Nodular Hepatocellular Carcinoma: Comparison of Treatment Outcomes. Liver Cancer. 2021 Feb; 10(1): 25-37 Co-first authors
8. Lee, D. H., Chung, J. W., Joo, I., Suh, K. S., Kim, S. H., Koh, Y. H., Lee, J. H., Cho, Y. K. & Park, J. W. Varices on computed tomography as predictor of survival after hepatic resection in patients with single hepatocellular carcinoma. Journal of Gastroenterology and Hepatology (Australia). 2021 Jan; 36(1): 225-232
9. Lee, D. H., Lee, E. S., Lee, J. Y., Bae, J. S., Kim, H., Lee, K. B., Yu, S. J., Cho, E. J., Lee, J. H., Cho, Y. Y., Han, J. K. & Choi, B. I. Two-dimensional-shear wave elastography with a propagation map: Prospective evaluation of liver fibrosis using histopathology as the reference standard. Korean Journal of Radiology. 2020 Dec; 21(12): 1322-1330
10. Yoon, J. S., Lee, D. H., Cho, E. J., Song, M. K., Choi, Y. H., Kim, G. B., Lee, Y. B., Lee, J. H., Yu, S. J., Kim, H., Kim, Y. J., Yoon, J. H. & Bae, E. J. Risk of liver cirrhosis and hepatocellular carcinoma after fontan operation: A need for surveillance. 2020 Jul; 12(7): 1-12 Co-first authors
11. Lee DH, Lee JY, Park MS, Han JK. Non-invasive monitoring of hepatic steatosis via acoustic structure quantification of ultrasonography with MR spectroscopy as the reference standard. 2020 Jan;39(1):70-78

12. Lee, D. H., Lee, J. M., Kim, P. N., Jang, Y. J., Kang, T. W., Rhim, H., Seo, J. W. & Lee, Y. J. Whole tumor ablation of locally recurred hepatocellular carcinoma including retained iodized oil after transarterial chemoembolization improves progression-free survival. European Radiology. 2019 Sep; 29(9): 5052-5062
13. Lee, D. H., Lee, J. M., Yu, M. H., Hur, B. Y., Yi, N. J., Lee, K. W., Suh, K. S., Yoon, J. H., Kim, Y. J., Lee, J. H., Yu, S. J. & Han, J. K. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC. European Radiology. 2019 Jun; 29(6): 3122-3131
14. Lee DH, Ahn JH, Chung JW, Kim YJ, Cha SW, Kim MY, Baik SK. Varices on computed tomography are surrogate of clinically significant portal hypertension and can predict survival in compensated cirrhosis patients. J Gastroenterol Hepatol. 2019 Feb;34(2):450-457. Co-first
15. Lee DH, Kim SH, Lee SM, Han JK. Prediction of Treatment Outcome of Chemotherapy Using Perfusion Computed Tomography in Patients with Unresectable Advanced Gastric Cancer. Korean J Radiol. 2019 Apr;20(4):589-598
16. Lee DH, Lee JY, Bae JS, Yi NJ, Lee KW, Suh KS, Kim H, Lee KB, Han JK. Shear-Wave Dispersion Slope from US Shear-Wave Elastography: Detection of Allograft Damage after Liver Transplantation. 2019 Nov;293(2):327-333
17. Lee DH, Lee JM, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK. Liver Stiffness Measured by Two-Dimensional Shear-Wave Elastography: Prognostic Value after Radiofrequency Ablation for Hepatocellular Carcinoma. Liver Cancer. 2018 Mar;7(1):65-75
18. Lee DH, Lee JM, Chang W, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK. Prognostic Role of Liver Stiffness Measurements Using Magnetic Resonance Elastography in Patients with Compensated Chronic Liver Disease. Eur Radiol. 2018 Aug;28(8):3513-3521
19. Lee DH, Lee JM, Kang TW, Rhim H, Kim SY, Shin YM, Seo JW, Choi MH, Lee KB. Clinical Outcomes of Radiofrequency Ablation for Early Hypovascular HCC: A Multicenter Retrospective Study. 2018 Jan;286(1):338-349
20. Lee DH, Kim SH, Joo I, Han JK. CT Perfusion evaluation of gastric cancer: correlation with histologic type. Eur Radiol. 2018 Feb;28(2):487-495
21. Lee DH. Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification. Clin Mol Hepatol. 2017 Dec;23(4):290-301
22. Lee DH, Lee JM. Primary malignant tumours in the non-cirrhotic liver. Eur J Radiol. 2017 Oct;95:349-361.
23. Lee DH, Lee JY, Lee KB, Han JK. Evaluation of Hepatic Steatosis by Using Acoustic Structure Quantification US in a Rat Model: Comparison with Pathologic Examination and MR Spectroscopy. 2017; 285: 445-453
24. Lee DH, Lee JM, Yoon JH, Kim YJ, Han JK. Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation. 2017 Mar;282(3):880-891.
25. Lee DH, Lee JM, Yi NJ, Lee KW, Suh KS, Lee JH, Lee KB, Han JK. Hepatic stiffness measurement by using MR elastography: prognostic values after hepatic resection for hepatocellular carcinoma. Eur Radiol. 2017 Apr;27(4):1713-1721.
26. Lee DH, Lee JM. Whole-body PET/MRI for colorectal cancer staging: Is it the way forward? J Magn Reson Imaging. 2017 Jan;45(1):21-35.
27. Lee DH, Lee JY, Han JK. Superb microvascular imaging technology for ultrasound examinations: Initial experiences for hepatic tumors. Eur J Radiol. 2016 Nov;85(11):2090-2095
28. Lee DH, Kim SH, Joo I, Hur BY, Han JK. Comparison between 18F-FDG PET/MRI and MDCT for the assessment of preoperative staging and resectability of gastric cancer. Eur J Radiol. 2016 Jun;85(6):1085-91
29. Lee DH, Kim SH, Im SA, Oh DY, Kim TY, Han JK. Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study. Eur Radiol. 2016 Aug;26(8):2771-8
30. Lee DH, Lee JM, Hur BY, Joo I, Yi NJ, Suh KS, Kang KW, Han JK. Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging. 2016 Sep;280(3):782-92
31. Lee DH, Lee JM, Klotz E, Han JK. Multiphasic Dynamic Computed Tomography Evaluation of Liver Tissue Perfusion Characteristics Using the Dual Maximum Slope Model in Patients with Cirrhosis and Hepatocellular Carcinoma: A Feasibility Study. Invest Radiol. 2016 Jul;51(7):430-4
32. Lee DH, Lee JM, Lee JY, Kim SH, Kim JH, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK, Choi BI. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation. Journal of Hepatology, 2015 May;62(5):1122-30
33. Lee DH, Lee JM, Baek JH, Shin CI, Han JK, Choi BI. Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging in the Detection of HCCs and Allocation of Transplant Recipients on the Basis of the Milan Criteria and UNOS Guidelines: Correlation with Histopathologic Findings. Radiology, 2015 Jan;274(1):149-160
34. Lee DH, Lee JM, Lee JY, Kim SH, Yoon JH, Kim YJ, Han JK, Choi BI. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. 2014 Mar;270(3):900-9
35. Lee DH, Lee JM, Lee JY, Kim SH, Han JK, Choi BI. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis. Cardiovasc Intervent Radiol. 2014 Jun;37(3):705-15
36. Lee DH, Lee JM, Klotz E, Kim SJ, Kim KW, Han JK, Choi BI. Detection of recurrent hepatocellular carcinoma in cirrhotic liver after transcatheter arterial chemoembolization: value of quantitative color mapping of the arterial enhancement fraction of the liver. Korean J Radiol. 2013 Jan-Feb;14(1):51-60
37. Lee DH, Lee JM, Han JK, Choi BI. MR elastography of healthy liver parenchyma: Normal value and reliability of the liver stiffness value measurement. J Magn Reson Imaging. 2013 Nov;38(5):1215-23
38. Lee DH, Kim YH, Lee YJ, Lee KH, Kim SY, Cho JY, Yoon YS, Han HS. CT findings of afferent loop varices after bilioenteric anastomosis in patients with malignant disease. AJR Am J Roentgenol. 2013 Jun;200(6):1261-8
39. Lee DH, Lee W, Kim KB, Cho KR, Park EA, Chung JW, Park JH. Availability of the right gastroepiploic artery for coronary artery bypass grafting: preoperative multidetector CT evaluation. Int J Cardiovasc Imaging. 2010 Dec;26(Suppl 2):303-10
40. Lee DH, Kim SH, Lee JM, Park HS, Lee JY, Yi NJ, Suh KS, Jang JJ, Han JK, Choi BI. Diagnostic performance of multidetector row computed tomography, superparamagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on milan criteria: correlation with histopathological findings Invest Radiol. 2009 Jun;44(6):311-21.  
41. Lee DH, Chung JW, Kim HC, Jae HJ, Yoon CJ, Kang SG, Jeon UB, So YH, Yin YH, Park JH. Development of diaphragmatic weakness after transcatheter arterial chemoembolization of the right inferior phrenic artery: frequency and determinant factors. J Vasc Interv Radiol. 2009 Apr;20(4):484-9
42. Lee DH, Lee JM, Kim KW, Park HS, Kim SH, Lee JY, Han JK, Choi BI. MR imaging findings of early bile duct cancer. J Magn Reson Imaging. 2008 Dec;28(6):1466-75

SCI Co-Author

1. Kim KW, Lee JM, Klotz E, Park HS, Lee DH, Kim JY, Kim SJ, Kim SH, Lee JY, Han JK, Choi BI. Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma. 2009 Feb;250(2):425-434
2. Yoon MA, Kim SH, Park HS, Lee DH, Lee JY, Han JK, Choi BI. Value of dual contrast liver MRI at 3.0 T in differentiating well-differentiated hepatocellular carcinomas from dysplastic nodules: preliminary results of multivariate analysis. Invest Radiol. 2009 Oct;44(10):641-9
3. Kim R, Lee JM, Joo I, Lee DH, Woo S, Han JK, Choi BI. Differentiation of lipid poor angiomyolipoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging. Abdom Imaging. 2015 Mar;40(3):531-41
4. Shin CI, Kim SH, Lee ES, Lee DH, Hwang EJ, Chung SY, Lee JM, Han JK, Choi BI. Ultra-low Peak Voltage CT Colonography: Effect of Iterative Reconstruction Algorithms on Performance of Radiologists Who Use Anthropomorphic Colonic Phantoms. 2014 Dec;273(3):759-71
5. Joo I, Lee JM, Lee DH, Jeon JH, Han JK, Choi BI. Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout? Eur Radiol. 2015 Oct;25(10):2859-68
6. Jang S, Lee JM, Lee DH, Joo I, Yoon JH, Chang W, Han JK. Value of MR elastography for the preoperative estimation of liver regeneration capacity in patients with hepatocellular carcinoma. J Magn Reson Imaging. 2017 Jun;45(6):1627-1636. doi: 10.1002/jmri.25517. Epub 2016 Nov 16.
7. Yoen H, Kim JH, Lee DH, Ahn SJ, Yoon JH, Han JK. Fate of small pancreatic cysts (<3 cm) after long-term follow-up: analysis of significant radiologic characteristics and proposal of follow-up strategies. Eur Radiol. 2016 Sep 21. [Epub ahead of print]
8. Ahn SJ, Lee JM, Lee DH, Lee SM, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. J Hepatol. 2017 Feb;66(2):347-354. doi: 10.1016/j.jhep.2016.09.003. Epub 2016 Sep 17.
9. Yoo H, Lee JM, Yoon JH, Lee DH, Chang W, Han JK. Prospective Comparison of Liver Stiffness Measurements between Two Point Shear Wave Elastography Methods: Virtual Touch Quantification and Elastography Point Quantification. Korean J Radiol. 2016 Sep-Oct;17(5):750-7.
10. Choi JW, Lee JM, Lee DH, Yoon JH, Suh KS, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK. Switching Monopolar Radiofrequency Ablation Using a Separable Cluster Electrode in Patients with Hepatocellular Carcinoma: A Prospective Study. PLoS One. 2016 Aug 30;11(8):e0161980.
11. Joo I, Lee JM, Lee DH, Lee ES, Paeng JC, Lee SJ, Jang JY, Kim SW, Ryu JK, Lee KB. Preoperative Assessment of Pancreatic Cancer with FDG PET/MR Imaging versus FDG PET/CT Plus Contrast-enhanced Multidetector CT: A Prospective Preliminary Study. 2017 Jan;282(1):149-159.
12. Joo I, Lee JM, Lee DH, Ahn SJ, Lee ES, Han JK. Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography. J Magn Reson Imaging. 2017 Mar;45(3):731-740. doi: 10.1002/jmri.25406. Epub 2016 Jul 30.
13. Lee M, Chung GE, Lee JH, Oh S, Nam JY, Chang Y, Cho H, Ahn H, Cho YY, Yoo JJ, Cho Y, Lee DH, Cho EJ, Yu SJ, Lee DH, Lee JM, Kim YJ, Yoon JH. Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment. 2017 Jun 15. doi: 10.1002/hep.29318. [Epub ahead of print]
14. Kim BR, Lee JM, Lee DH, Yoon JH, Hur BY, Suh KS, Yi NJ, Lee KB, Han JK Diagnostic Performance of Gadoxetic Acid-enhanced Liver MR Imaging versus Multidetector CT in the Detection of Dysplastic Nodules and Early Hepatocellular Carcinoma.. 2017 Jun 13:162080. doi: 10.1148/radiol.2017162080. [Epub ahead of print]
15. Bae JS, Kim JH, Yu MH, Lee DH, Kim HC, Chung JW, Han JK. Diagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS). PLoS One. 2017 May 30;12(5):e0178495. doi: 10.1371/journal.pone.0178495. eCollection 2017.
16. Yoo JJ, Chung GE, Lee JH, Nam JY, Chang Y, Lee JM, Lee DH, Kim HY, Cho EJ, Yu SJ, Kim YJ, Yoon JH; Seoul Liver Group. Sub-Classification of Advance-Stage Hepatocellular Carcinoma: A Cohort Study Including 612 Patients Treated with Sorafenib. Cancer Res Treat. 2017 May 15. doi: 10.4143/crt.2017.126. [Epub ahead of print]
17. Chang W, Lee JM, Yoon JH, Lee DH, Lee SM, Lee KB, Kim BR, Kim TH, Lee S, Han JK. No-touch radiofrequency ablation using multiple electrodes: An in vivo comparison study of switching monopolar versus switching bipolar modes in porcine livers. PLoS One. 2017 Apr 26;12(4):e0176350. doi: 10.1371/journal.pone.0176350. eCollection 2017.
18. Park J, Lee JM, Lee DH, Joo I, Yoon JH, Park JY, Klotz E. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol. 2017 Jun;40(6):873-883. doi: 10.1007/s00270-017-1571-y. Epub 2017 Jan 13.
19. Joo I, Lee JY, Lee DH, Jeon JH, Kim H, Yi NJ, Lee KW, Suh KS. Contrast-Enhanced Ultrasound Using Perfluorobutane-Containing Microbubbles in the Assessment of Liver Allograft Damage: An Exploratory Prospective Study. Ultrasound Med Biol. 2017 Mar;43(3):621-628. doi: 10.1016/j.ultrasmedbio.2016.11.012. Epub 2016 Dec 29.

Specialties

Hepatobiliary and Pancreatic Surgery

Biography

Domenech Asbun, M.D., is a hepatobiliary, pancreas and foregut surgeon at Miami Cancer Institute. Dr. Domenech Asbun specializes in minimally invasive surgical procedures to treat liver, pancreatic and upper gastrointestinal diseases. Prior to joining Miami Cancer Institute in 2021, Dr. Domenech Asbun completed a fellowship in minimally invasive hepatopancreatobiliary (HPB) and foregut surgery at the Mayo Clinic Hospital Florida. He has presented at national and international academic meetings and has published research in multiple high-impact journals. Apart from HPB surgery, he has a strong interest in global surgery and surgical simulation.

Dr. Alda Tam is a tenured Professor in the Department of Interventional Radiology at the University of Texas M.D. Anderson Cancer Center. Dr. Tam earned her undergraduate degree in neuroscience from Brown University, medical degree from the University of British Columbia, and masters in business administration from the University of California, Irvine. She completed her diagnostic radiology residency at the University of Southern California, interventional radiology fellowship at MD Anderson Cancer Center, and subsequently joined the faculty in 2006.  Dr. Tam serves as the Executive Director of Diagnostic Imaging for the MD Anderson Cancer Network and maintains an active interventional radiology practice with involvement in both translational and clinical trials. Dr. Tam is an inducted fellow of the Society of Interventional Radiology (SIR) and American College of Radiology (ACR).  She is the President-Elect of the SIR.

Shu-Huei Shen, MD of Taipei, Taiwan, is an expert in the field of genitourinary radiology. Graduating from National Taiwan University School of Medicine, Dr. Shen had full-course residency training in the Department of Radiology, Taipei Veterans General Hospital. She is an attending physician in the genitourinary radiology section in Taipei Veterans General Hospital. Her main research activities include diagnostic radiology in urologic and gynecological images. Dr. Shen is also expert in body interventional procedures. After the fellowship training in Brigham and Women’s hospital (Boston, MA) in 2008, Dr. Shen has been devoted to imaging guided tumor ablation, focusing on the cryoablation. Dr. Shen has authored many papers in peer-reviewed journals and has been the assistant professor of National Yang Ming school of Medicine. She is currently the chief of the interventional radiology division.

Reshma Mahtani, D.O., is a medical oncologist at Miami Cancer Institute and chief of breast medical oncology for Baptist Health Wellness and Medical Complex. Dr. Mahtani’s practice is limited to the treatment of breast cancer. Prior to joining Miami Cancer Institute in 2022, Dr. Mahtani worked as an associate professor of medicine and co-leader of the Breast Cancer Site Disease Group at the University of Miami Miller School of Medicine. She was also the director of community outreach. Dr. Mahtani is an active clinical researcher, helping bring novel breast cancer treatments and clinical trials to patients in South Florida. She has made significant scientific and clinical practice contributions with numerous first-author publications in peer-reviewed journals. She is a nationally recognized thought leader in breast cancer and has presented her cancer research findings at cancer conferences worldwide. She has received funding from numerous organizations. Dr. Mahtani served on national committees to recognize cancer clinics that offer quality care across the country. She is involved in several initiatives that enhance patients’ access to healthcare, as well as community collaborations for education and advocacy. She founded a medical education initiative to ensure that physicians in South Florida know about the latest cancer treatments and can provide evidence-based care. Though she is a passionate researcher, Dr. Mahtani most enjoys spending time with her patients. She believes it is a privilege to be by their side, teaching them about their breast cancer and their treatment options. She strives to help every patient find hope through clinical trials and the latest immunotherapies and targeted therapies for breast cancer. When she is not treating patients, she enjoys seeing the world with her family.

Dr. David S. Lu is a UCLA Health radiologist with a unique blend of training and interests that focus on cancer in a field called interventional oncology. Patients who work with Dr. Lu receive new imaging from a specialist point of view, with recommendations for the most minimally invasive therapies possible to treat their cancer. Get to know Dr. Lu: https://www.uclahealth.org/david-lu Book an appointment: 310-301-6800 More info: https://www.uclahealth.org/radiology

David J.Breen MBBS MRCP FRCR is a Consultant Radiologist specializing in Interventional Oncology at the University Hospital Southampton. He has trained in London, Oxford, and Vancouver where he developed a special interest in image-guided ablation of small volume cancers. He is now acknowledged as a pioneer in the development and application of both Cryoablation and Microwave ablation. Dr. Breen has worked for the Trust since 2001. His role involves imaging and intervention in non-vascular abdominal disease. He is an associate professor of radiology. He is internationally recognized as a pioneer in the image-guided ablation of abdominal disease using radiofrequency thermal ablation and cryoablation to destroy abdominal cancers. He is teaching widely in the UK and internationally in the interpretation and optimization of abdominal imaging, particularly liver, pancreatic, and kidney disease.

Maria del Pilar Bayona Molano, M.D., is an Associate Professor of Radiology at UT Southwestern Medical Center, and a member of its Vascular & Interventional Radiology Division.

Charles Jonathan Lugo, MD is a diagnostic radiologist in Stony Brook University, NY specializing in diagnostic radiology. He graduated from University of Wisconsin School of Medicine and Public Health in 2014 and has 8 years of experience. Charles Jonathan Lugo, MD is affiliated with Stony Brook Medicine.

Richard S. Finn, MD
Professor
Department of Medicine
Division of Hematology/ Oncology
UCLA David Geffen School of Medicine
Director, Signal Transduction and Therapeutics Program,
Jonsson Comprehensive Cancer Center
University of California, Los Angeles

Dr Finn is a Professor of Clinical Medicine in the Division of Hematology/ Oncology at the UCLA David Geffen School of Medicine and Director of the Signal Transduction Program in the Jonsson Comprehensive Cancer Center at UCLA.

He currently splits his time between patient care and laboratory and clinical research. His research interests lie in the development of molecular targeted agents and biomarkers in liver cancer and breast cancer. Dr Finn has served as principal and sub-investigator in trials exploring the use of targeted therapies in breast and hepatocellular cancers. He has a particular interest in identifying predictive markers of response to novel therapeutics. His work has been published in journals such as the New England Journal of Medicine, The Lancet, Journal of Clinical Oncology, Lancet Oncology, Cancer Research, Clinical Cancer Research, Hepatology, Cancer Cell and elsewhere. Dr Finn has also given oral presentations at major meetings including American Society of Clinical Oncology (ASCO), European Cancer Conference (ECCO/ ESMO), and the American Association of Cancer Research (AACR) and others. An active cancer researcher, he has been involved in the development of several novel therapeutics in cancer medicine. He has brought several practice changing advances to cancer medicine. He played a lead role in the approval of palbociclib (Ibrance), the first CDK 4/6 inhibitor in cancer medicine, from pre-clinical development to global registration and more recently the combination of atezolizumab and bevacizumab for the treatment of advanced liver cancer.

Dr Finn is a member of ASCO, American Association of Cancer Research (AACR) and the European Society of Medical Oncology (ESMO). He is a past president of the International Liver Cancer Association (ILCA). He is on the editorial board of Clinical Cancer Research.

Dr. Antonio Ucar is a medical oncologist at the Miami Cancer Institute, part of Baptist Health South Florida and has over 35 years of experience in the field of medicine. He is the Principal Investigator of several clinical trials in gastrointestinal cancers at the Miami Cancer Institute.

He received his medical degree from the University of Panama School of Medicine. Dr Ucar completed internal medicine residency and hematology and oncology fellowships at the University of Miami/Jackson Memorial Hospital and is certified in Medical Oncology and Hematology by the ABIM. He is the chair of the gastrointestinal cancers disease management team at the Miami Cancer Institute.

Caio Max S. Rocha Lima, M.D. is the M. Robert Cooper Professor in Medical Oncology. He is the Co-leader GI Oncology and Co-leader Phase I Programs at the Division of Hematology and Oncology at Wake Forest School of Medicine in Winston-Salem, NC. Prior to join Wake Forest School of Medicine, Dr. Rocha Lima was the Associate Cancer Center Director for Translational Research Gibbs Cancer Center & Research Institute and CMO Guardian Research Network Dr. Rocha Lima received his medical degree from the Federal University of Bahia-Salvador and later pursued residency training at the Clinical Hospital of Sao Paulo University; both in his native country of Brazil.

Afterwards Dr. Rocha Lima completed a fellowship in hematology/oncology at the Medical University of South Carolina. Dr. Rocha Lima was an assistant Professor of Medicine at Moffitt Cancer Center in Tampa, Fl. As a full Professor, at the University of Miami, he was the Program Co-Leader for Pancreatic/Hepatobiliary and Colorectal Cancer Site Disease Groups. He also co-lead the Phase I program at the University of Miami. Dr. Rocha Lima’s professional memberships include the American Society of Hematology, The American Society of Clinical Oncology, the East Cooperative Oncology Group, and the European Society of Medical Oncology, where he served as the USA ASCO representative in 2002-2003.

Dr. Rocha Lima has engaged in a considerable number of studies that investigate the use of novel agents to treat solid tumors, including pancreatic cancer, lung cancer, and colorectal cancers. He was frequently involved as a principal or co-investigator in many clinical trials including the PI of a phase III trial that involved the Americas, Asia and Australia in Pancreas cancer. Dr. Rocha Lima’s research has been widely published in journals such as Journal of Clinical Oncology, Chest, Oncology, Seminars in Oncology, Cancer, and The Annals of Oncology.

Riccardo Lencioni, MD, FSIR, EBIR, is Professor of Radiology at the University of Pisa School of Medicine in Pisa, Italy, and Honorary Research Professor of Interventional Oncology at the Miami Cancer Institute in Miami, USA. He was previously Professor of Radiology and Director of Interventional Oncology Research at the University of Miami School of Medicine. Professor Lencioni is one of the world’s foremost interventional oncology specialists, known especially for his highly influential work in liver cancer. He has been the principal investigator of several large, multicenter, randomized clinical trials investigating the use of image-guided interventions for the treatment of hepatocellular carcinoma and the potential synergies between loco-regional therapies and systemic agents. Professor Lencioni has been a leading member of several expert panels developing recommendations for research and clinical management of hepatocellular carcinoma.

He is also known for having developed modified RECIST criteria for the assessment of tumor response in hepatocellular carcinoma. Riccardo Lencioni has been the Founding Chairman of the European Conference of Interventional Oncology, a co-Founder and Chairman of the World Conference of Interventional Oncology, and a Founding Governing Board Member and Executive Secretary of the International Liver Cancer Association. Riccardo Lencioni has published 206 articles in peer-reviewed international journals indexed in PubMed and numerous chapters in textbooks of interventional radiology, gastroenterology, oncology and surgery. In addition, he has been the editor of nine books. According to the SCOPUS database, citations of his publications currently number in excess of 21,000, for an h-index of 60. Riccardo Lencioni has received numerous international awards for his research and has been an invited or honorary lecturer at more than 500 international meetings or conferences held in 65 different countries.

Nishita Kothary, M.D. is a Professor of Radiology in the section of Interventional Radiology at Stanford University Medical Center. Dr. Kothary’s clinical practice primarily focuses on percutaneous and endovascular therapies for primary and metastatic liver cancer. Her research interests lie in radiogenomics and in the use of advanced imaging in the diagnosis and treatment of hepatocellular carcinoma (HCC). Dr. Kothary is an active member of the Zeego Lab and Integrative Biomedical Imaging Informatics at Stanford. She is the faculty lead for the Out-of-OR Value-based Committee and the co-chair for the overall SHC Value-based Committee.

Horacio Asbun, M.D., FACS, is a surgical oncologist specializing in the treatment of cancers and diseases of the liver, gallbladder, biliary system and pancreas. He is chief of Hepatobiliary and Pancreatic Surgery at Miami Cancer Institute. Prior to this role, he served as director of the Hepatobiliary and Pancreas Program and chairman of General Surgery at Mayo Clinic in Jacksonville, Fla. Throughout his career, Dr. Asbun repeatedly has been named a Top Doctor by U.S. News & World Report and Castle Connelly Ltd. Dr. Asbun is actively involved in clinical research to improve treatment efficacy and patient outcomes. He has published more than 100 scientific articles and 30 book chapters and serves as editor-in-chief of the American College of Surgeons Multimedia Atlas and reviewer for numerous scientific journals. He directs and teaches national courses on surgery and speaks frequently at scientific conferences around the world, with more than 300 presentations to date. He also serves on the boards and committees of several national and international professional societies.

Dr. Hevert graduated from Pepperdine University with a bachelor’s degree in psychology. She went on to Florida Atlantic University, where she earned a master’s degree in biomedical science. She received her medical degree from University of Miami Leonard M. Miller School of Medicine, and served an internship in internal medicine at University of Miami Miller School of Medicine’s Palm Beach campus, garnering its 2013 Intern of the Year award.

Dr. Hevert served a residency in diagnostic radiology at UM’s Jackson Memorial Hospital, where she won the Interventional Radiology Resident of the Year award three years in a row, 2015-2017. She also garnered the 2015 Thoracic Radiology Resident of the Year award.

Dr. Hevert achieved a fellowship in interventional radiology from Massachusetts General Hospital. She has published and contributed to an extensive list of research papers regarding interventional therapies to treat and manage cancer, among others. An advocate of community service, Dr. Hevert has contributed to various organizations, including Big Brothers Big Sisters of Miami, the Department of Community Services and other outreach facilities.

Sarah B. White, MD, is a professor of radiology in the Division of Vascular Interventional Radiology who comes to the Medical College of Wisconsin after completing the Diagnostic & Interventional Radiology Enhanced Clinical Training Pathway (DIRECT) at the Hospital of the University of Pennsylvania in Philadelphia, PA.

Both prior to and during her radiology residency training, Dr. White has been active in research publishing several papers as first author, as well as presenting at local, regional and national meetings. Dr. White started her career in research in a molecular biology laboratory at the University of Pennsylvania and has spent time at the National Institute of Health. Dr. White has received awards for her research from several national organizations, including the Society of Interventional Radiology (SIR), the Association of University Radiologists (AUR) and the Radiologic Society of North America (RSNA), and was the Constantine Cope Cook Interventional Radiology endowed fellow at the University of Pennsylvania.

Dr. White will now focus on clinical and translational research in the Division of Vascular Interventional Radiology with an interest in translational research and quality assurance.

Education and Training

• Doctor of Medicine – New Jersey Medical School – Newark, NJ (2005)
• Resident (DIRECT Pathway) Surgery/Radiology – University of Pennsylvania – Philadelphia, PA (2005-2011)
• Fellow Radiology/Interventional Radiology – University of Pennsylvania – Philadelphia, PA (2009-2010)

Associate Professor, Radiation Oncology, Surgery, Orthopaedic Surgery & Graduate School of Biomedical Sciences

Education – MD, University of Missouri-Kansas City, Kansas City, MO, 2008

Training
Preliminary Internship in Medicine, Saint Louis University Hospitals, Saint Louis, MO (2008-2009)
Residency, Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI (2009-2013)

Certifications
Radiation Oncology, American Board of Radiology (2014)

Patient Care Emphases
Sarcomas
Gynecological Cancers
Genitourinary Cancers
Prostate Cancer

Yolanda Bryce, MD, RPVI completed her Medical School training at Loma Linda University School of Medicine in 2009, followed by a Diagnostic Radiology Residency at Mount Auburn Hospital in Cambridge, Massachusetts in 2014, a subspecialty training in Breast Imaging at Memorial Sloan Kettering Cancer Center (MSKCC) in 2015, and a Fellowship in Vascular and Interventional Radiology at Miami Cardiac and Vascular Institute in 2016.

She joined the faculty at Memorial Sloan Kettering Cancer Center in August 2016 where she probes the intersection of her subspecialties, pioneering minimally invasive cryoablation technique to treat locoregional disease in patients that are poor surgical candidates or refuse surgery. She serves as her institution’s co-Principal Investigator (PI) for a multi-institutional trial that evaluates the outcome of combining cryoablation and immunotherapy in breast cancer and will serve as PI for a new trial evaluating immune response in cryoablation and metastatic triple negative breast cancer.

She also specializes in vascular disease in oncologic patients, boarded through the American Board of Vascular Medicine and holding a Registered Physician Vascular Interpretation (RPVI) certification. In 2018, she became the founding director of MSKCC’s Noninvasive Vascular Imaging Center and started the institution’s Peripheral Arterial Disease (PAD) program improving mobility and quality of life of some of the most vulnerable patients – those with both cancer and life-limiting PAD. Her new trial will examine the benefit of screening for PAD in at-risk cancer patients. She is also program director of the Interventional Radiology Residency and Interventional Oncology Fellowship programs at MSKCC, revamping their infrastructure and vision.

Rupesh Kotecha, M.D., is a board-certified radiation oncologist and Chief of Radiosurgery in the Department of Radiation Oncology and Director of the Central Nervous System (CNS) Metastasis program at Miami Cancer Institute. He is an associate professor in the departments of radiation oncology and translational medicine at the FIU Herbert Wertheim College of Medicine.

He has specialized training and experience in utilizing the latest techniques in radiation therapy for both cancer and noncancerous conditions. His research background and clinical interests have primarily focused on the treatment of patients with stereotactic radiotherapy, including CyberKnife, LINAC-based, and GammaKnife radiosurgery, and stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR). He also specializes in advanced radiation therapy treatment techniques, including re-irradiation, proton beam radiotherapy, and MR-guided radiation therapy.

During medical school, Dr. Kotecha was inducted into the Alpha Omega Alpha Honor Medical Society, an organization that recognizes excellence in scholarship and the profession of medicine. He has been an invited speaker at numerous national and international symposiums, and has published multiple book chapters and over 100 manuscripts in peer-reviewed journals. His research bandwidth spans investigator-initiated studies to multi-center trials to national cooperative group clinical protocols. Dr. Kotecha serves as the CNS co-chair for the Proton Collaborative Group, coordinates the NCI Glioblastoma Clinical Interest Group, and is a course director for the annual Miami Brain Symposium. He is an editorial contributor and advisory board member on the topic of brain cancer for Practice Update, an online resource for healthcare providers throughout the United States and around the world.

Procedures Performed:

• 3-D conformal radiotherapy
• Brachytherapy
• External beam radiotherapy
• Gamma Knife radiosurgery
• Cyberknife radiosurgery
• Image-guided radiation therapy
• Intensity modulated radiation therapy
• Stereotactic body radiotherapy
• Stereotactic ablative radiotherapy
• Re-irradiation
• Spatially fractionated radiotherapy
• MR-guided radiotherapy
• Proton beam radiotherapy
• Cardiac radiosurgery

Education, Fellowship, & Training
Medical School- Michigan State University College of Human Medicine, East Lansing, Mich.
Residency – Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio

Dr. Gandhi did his undergraduate studies at Northwestern University and Harvard University. He graduated summa cum laude (highest honors). He received his degree in medicine from Northwestern University Medical School, where he also graduated with honors. Following medical school, he completed a surgical internship at Cornell University Medical Center and New York Presbyterian Hospital. He completed his residency training and fellowship at UCLA Medical Center. Currently, he is clinical professor at the University of South Florida School of Medicine and FIU Herbert Wertheim College of Medicine. Dr. Gandhi regularly trains other physicians in various vascular/endovascular, interventional radiology, and interventional oncology techniques.

Because of his interest in discovering new therapies, Dr. Gandhi also dedicated an entire year to biomedical research at the renowned Memorial Sloan-Kettering Cancer Center in New York. He also served as a research fellow at the National Institutes of Health (NIH). He has published his findings in several scientific journals and also authored several textbook chapters and presented his research at national and international meetings.  Dr. Gandhi is the recipient of multiple awards. He is the co-author of the textbook Interventional Oncology which was recently published.  He is a program director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).

Dr. Bayona Molano is board certified in Diagnostic Radiology and earned her certificate of added qualification (CAQ) in Interventional Radiology from the American Board of Radiology.

Dr Bayona has over 15 years of clinical, teaching and research experience in vascular and interventional radiology. She has worked in UT Southwestern Medical Center in Dallas. Her clinical interest includes Transplant interventions, interventional oncology and portal hypertension. In these areas she has presented many invited lectures and has published her work in reputed journals.

She has been active as an educator and has delivered many invited lecturers at specialty meetings both in the national and international platforms. She is an active member of the SIR and SIO and participates in multiple committees. She also has been participating in multicenter clinical trials. Her interest in education has earned her university professor ships and mentorship awards. She is a featured editor for Journal of Vascular Interventional Radiology and have been participate in other journals like Journal of Cardiac Surgery, Cardiovascular and Interventional Radiology, and Hepatology.

Luis E. Raez, MD, FACP, FCCP; is the President of the Florida Society of Clinical Oncology (FLASCO). He works as Chief Scientific Officer & Medical Director of Memorial Cancer Institute (MCI), he is also Director of the Thoracic Oncology Program.

He is Co-Director of the MCI/FAU Florida Cancer Center of Excellence designated by the Florida governor, one of the 5 centers in Florida. He is also Clinical Professor of Medicine at FIU, Visiting Professor of Medicine at Cayetano Heredia University in Peru and Associate Professor of Clinical Biomedical Science for FAU. He was also faculty at Sylvester Cancer Center/University of Miami for 10 years (2001-2011).

He has expertise in medical oncology in the areas of lung cancer, and head and neck cancer. He designs phase I-III clinical trials with new chemotherapeutic agents and combinations. He has given oral presentations in 5 continents. He is American Board Certified in: Internal Medicine and Medical Oncology. He is board eligible in Hematology.

Dr. Prologo is an interventional radiologist whose research has focused on the application of image guided techniques to the delivery of stem cell therapies, the treatment of pain, and for management of complex metabolic conditions – specifically through integration of interventional cryoneurolysis procedures to patient care algorithms. He is an Associate Professor in the Department of Radiology and Imaging Sciences at Emory University in Atlanta, GA – and is the author of The Catching Point Transformation: A Twelve Week Weight Loss Strategy Based in Reality.

Dr Uthappa has been a consultant interventional radiologist for 5 years in UK and for the past 13 years in Bangalore. He has performed over 18,500 procedures in the last 20 years.

He has performed various vascular interventions (Angiograms, Angioplasty, Venoplasty, Vascular stenting), Hepatobiliary interventions (Chemoembolization and Radioembolization for liver tumors, embolization in hepatic arterial and venous injury, RF ablation for liver tumors, Biliary drainage and stenting, Hepatic vein stenting, TIPSS), GI interventions (mesenteric angiograms, SMA stenting, Embolization for various forms of GI bleeding, Esophageal dilatation and stenting), Urology interventions (nephrostomy, ureteric stenting, Varicocele embolization), Gynecology procedures (Fallopian tube recanalization, Uterine fibroid embolization, Ovarian vein embolization, embolization procedures in high risk pregnancy), embolization of vascular malformations, Varicose vein ablation procedures, RF ablation for Palliation in various forms of cancers and Central venous access for dialysis and chemotherapy. In the last one year he has performed the first case prostate artery embolization and microwave ablation for liver cancer in south India.

Fellowship & Membership
• KMC, India
• GMC, UK
• RSNA, USA
• CIRSE, Europe
• IRIA, India
• ISVIR, India

Awards & Achievements
• PM award for best cadet in NCC, 1987
• Gold medal in Medical College, 1993
• First to start Raioembolisation (TARE) for advanced liver cancer in south India, 2008
• First to start Microwave ablation for liver cancer in south India, 2016
• First to start Prostate Artery Embolization in south India, 2016
• First to set up a dedicated department of Interventional Radiology and interventional Oncology (IRIO) in Private Hospitals. India, 2011
• Started an educational CME for radiology students called GIRS (global interventional radiology symposium), 2013
• First to start Interventional Radiology training in private hospitals in Bangalore and Chennai, 2011

Field of Expertise
• Hepatobiliary and GI interventions
• Interventional Oncology
• Uterine Fibroid embolization (UFE)
• Prostate artery embolization (PAE)

Arvin George, MD is a Urologic Surgeon specializing in the diagnosis and management of genitourinary cancers.  After obtaining his medical degree from the Royal College of Surgeons in Ireland, he completed his Urology Residency at the Smith Institute for Urology, Hofstra North Shore-LIJ School of Medicine.  He remained to complete his Endourology fellowship in New York gaining additional subspecialty expertise in robotic, laparoscopic, and percutaneous surgery.  Subsequently, he completed a Urologic Oncology fellowship at the National Cancer Institute, National Institutes of Health.  Dr. George’s clinical practice includes both surgical and non-operative management of prostate, kidney, ureteral, testicular, and bladder cancers.  Dr. George’s research interests include minimally invasive and image-guided treatments, functional prostate imaging and focal therapy for prostate cancer.

Areas of Interest

Research:

Dr. George’s research focuses on the use of prostate MRI, MR/Ultrasound fusion-guided prostate biopsy, and focal therapy for prostate cancer. His research aims to identify appropriate use for imaging in diagnosis, risk stratification, and management of prostate cancer including active surveillance and selection/treatment of patients with novel focal therapy modalities.

Clinical Interests

Prostate Cancer (Robotic Prostatectomy, Focal Therapy), Kidney Cancer (Robotic/Laparoscopic, Open surgery), Bladder Cancer, Testis Cancer.

Credentials

Medical School:

Royal College of Surgeons in Ireland, 2007

Residency:

Hofstra North Shore-LIJ School of Medicine, General Surgery, NY, 2008
Hofstra North Shore-LIJ School of Medicine, Urology, NY, 2012

Fellowship:

Endourology, The Smith Insitute for Urology, Hofstra-North Shore LIJ School of Medicine, 2013
Urologic Oncology, National Cancer Institute, National Institutes of Health, 2016

Professional Organizations:

American Urological Association
Society of Urologic Oncology
Endourological Society
American College of Surgeons

Dr. Deepa Shree is a MRCP FRCR CCT (UK) & European board certified in Interventional Radiology. She heads the dept of interventional radiology at Dr Rela institute and medical centre. She is also the Interventional Radiology Fellowship Program Director. Apart from her core expertise, Dr. Deepa is immensely passionate about helping others with mental wellbeing & holistic health. Now she adores not just this zeal, but also the right credentials, life-tested experience along with happy testimonials that followed from those who benefited. Dr. Deepa is a Certified psychologist & belief clearing practitioner. She is also a Zumba instructor helping people with their fitness goals. Determined to do more, Dr. Deepa ventured into writing through her debut book “Art of balance”.

She is also a Motivational Speaker, with experience in delivering workshops, development training to the Big5’s & MNCs. She has a devoted following on social media platforms, many of whom actively seek Dr’s guidance, motivation, or wisdom in different walks of life. Dr. Deepa wanted to take this further to help more people. Thus, was born her new book “Magnetic Of Mind” which is launching soon on Amazon Kindle platforms. The book is an easy-to-use guide about the positive & negative poles within each of us. It is an attempt to kindle inspiration to explore these poles, so that one can engineer one’s life as desired. Packed with research, life stories, personal experiences & even mistakes to learn from, the author feels the book could be a life-changing read. Hope the book helps you have your poles controlled your way towards bliss & beyond. Happy reading.

More feathers to Dr. Deepa’s hat –

• One of the Winners of south India’s Iconic women award 2019
• Winner of Icons of greater Chennai 2020 (health Care and medical services)
• SIWAA award winner 2020

Dr. Bhavesh Thakkar
MBBS, MD (Medicine), DNB (Gastro) – Gold Medalist
Practising Since : 2009
Specialisation

Gastroenterology

Profile

Dr. Bhavesh Thakkar is a proficient Gastroenterologist from Ahmedabad spearheading the Department of Gastroenterology at CIMS Hospital as HOD. Apart from this, Dr. Thakkar is also a visiting Gastroenterologist at Gujarat Cancer Research Institute, Ahmedabad since Jan 2014.
Dr. Thakkar, an alumnus of Govt M P Shah Medical College (Jamnagar), has completed post graduation in MD (Medicine). Furthermore, Dr. Thakkar finalized DNB (Gastroenterology) from Apollo Hospital, Chennai during… [+]

Testimonials

Research

Thesis work: “Endoscopic ultrasound guided FNAC and cystic fluid analysis for pancreatic and peripancreatic mass lesions” A study of 50 cases.
Training
Teaching experience as Assistant Professor, Department of Medicine, MP Shah Medical College, Jamnagar.

Publications

• Presentation
  Yield of EUS guided FNAC for pancreatic and peripancreatic mass lesions: at ISGCON 2011, Coimbatore.
• Presentation
  Spectrum of microbial flora in bile collected during ERCP in cholangitis patients, at ISGCON 2011, Coimbatore.
• Presentation
  Microscopic changes in non erosive reflux disease patients, at ISGCON 2010-2011, Coimbatore.

Accreditation

• Member, Indian Society of Gastroenterology (ISG).
• Member, Indian Society of Gastroenterology, Tamilnadu Chapter (ISG-TN).
• Member, Indian National Association of Study on Liver (INASL).

Dr. Nitin Shetty is a radiologist in Mumbai, Maharashtra, India. Dr. Nitin Shetty is affiliated with Tata Memorial Hospital, Mumbai. Dr. Nitin Shetty provides diagnosis of various diseases using imaging modalities like X- rays, CT scan, MRI etc. Here you can find contact information like phone number and reviews for Dr. Nitin Shetty.

Specialities

 Diagnostic Radiology
A radiologist is a medical professional who has been trained to diagnose injuries and diseases with the use of x-rays. Radiologists can diagnose a variety of different diseases and injuries. They can also determine the severity of the problem through imaging scans.

Affiliated Hospitals

Tata Memorial Hospital, Mumbai

Consultant radiologist at Tata Memorial Hospital with special interest in Breast, Gynaecological and Urological malignancies.

Palak Bhavesh Thakkar – Palak Popat
Associate Professor & Consultant
Department of Radiodiagnosis
Tata Memorial Centre
Mumbai

Associate Prof

Radiation Oncology

Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer
India

Biography
2013 has seen the institution expand its activities outside its traditional bastion of Mumbai with projects at Vizag, Chandigarh, Sangrur, in addition to the cancer registries that are being setup all over the country. This notwithstanding, there has been a lot of activity at Parel as well, towards our mission of providing the best cancer care to all who seek treatment at the hospital. We are constantly mindful of the fact that the existing infrastructure at the hospital is stretched given the patient load. The majority of our efforts and initiatives are therefore directed at being patient friendly.Towards these goals we augmented our semiprivate bed strength where wait lists were over 6- 8 weeks by converting the old private wards in the main building to semi private accommodation. The private rooms are now exclusively housed in the new Homi Bhabha block. This helps in accommodating more patients while maintain the 60:40 general to private ratio. Our smart card transactions have now been expanded to cover the inpatient services and the general category patients as well. The smart card ensures that all services at the hospital are now cashless, saving time patients spent in long queues. In addition, smart card kiosks are setup all over the outpatient areas to help patients to check balances, expenditures, deposits as well as status of their reports. Patients now also get SMS alerts of their smart card transactions. Towards a green environment our paperless operations have been expanded with no printing of patient reports and pharmacy memos. Patients can however view and prints reports at any time from any location as these are available on the web with restricted access only to the patient and his / her treating clinician.Infrastructure has been augmented with the installation of high value equipment that includes a digital mammography, augmentation of the minimal invasive surgical capabilities, surgical microscopes and anesthesia delivery systems.There has been a major revamp of the hospital Institutional Review Board with space allocated for a dedicated trial pharmacy. In addition, our pediatric ward and outpatient clinic have had a major revamp through a generous philanthropic gesture, making it more child friendly for our young patients. Our service to the Rajiv Gandhi Jeevan Arogya Yojana for patients below the poverty line initiated by Government of Maharashtra has been well appreciated, with the hospital recognized as the leader in the care of cancer patients under this scheme.A financial management system with the help of the ECIL is also fully implemented putting inplace greater accountability and ease in our accounting process. These efforts are reflected in the fact that we have won the best Oncology hospital award by CNBC – ICICI Lombard for the 4th year in running. I place on record the contribution of each and every one of our staff who many a time, work well beyond the call of normal duty.

Research Interest

Oncology

Specialties

Cutaneous (skin) Cancer Surgery

Qualifications

Chief of Melanoma & Soft Tissue Sarcoma Surgery

Publications

https://www.ncbi.nlm.nih.gov/pubmed/?term=Jimenez%2C+Ramon+e

Education and Training

• Memorial Sloan Kettering Cancer Center
• Fellowship Program, Complex Surgical Oncology, Gen, 2003
• Massachusetts General Hospital
• Residency Program, Surgery, General, 2001
• Massachusetts General Hospital
• Residency Program, Surgery, General, 1997
• Johns Hopkins University School of Medicine (Maryland)
• Medical School, MD, 1994

Certifications

Surgery
American Board of Surgery, 2002

Miami Cancer Institute Names Ramon Jimenez, M.D., FACS, Chief of the Division of Melanoma and Soft Tissue Sarcomas

MIAMI, FL – October 9, 2017 – Surgical oncologist Ramon Jimenez, M.D., FACS, has joined the world-class team of specialists at Miami Cancer Institute at Baptist Health South Florida, the region’s premier cancer treatment and research destination. Dr. Jimenez will serve as chief of melanoma and soft tissue sarcoma surgery. Highly experienced in utilizing innovative surgical techniques to treat a wide variety of cancers requiring surgical intervention, he specializes in the surgical treatment of melanoma and soft tissue sarcomas — the latter referring to rare cancers that start in the soft tissues of the body, such as fat and muscle.

In practice for more than 20 years, Dr. Jimenez will collaborate with the Institute’s multidisciplinary teams of cancer care specialists, including pathologists, medical oncologists, radiation oncologists and patient support specialists, to provide the most effective treatment plan for each patient.
“Treating rare cancers requires rare skill, and Miami Cancer Institute continues to build an interdisciplinary cancer care team composed of specialists who are experts in their fields,” said Michael J. Zinner, M.D., founding CEO and executive medical director of Miami Cancer Institute. “The appointment of Dr. Jimenez at the Institute is evidence of our commitment to providing each patient with the most advanced, effective cancer care.”

Dr. Jimenez, who is Board-certified in general surgery, received his undergraduate degree in biology from Yale University, graduating summa cum laude, and earned his medical degree at the Johns Hopkins University School of Medicine. He completed a general surgical residency at Massachusetts General Hospital, followed by a fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center. His postdoctoral training also included a surgical research fellowship at Harvard Medical School.

Prior to joining Miami Cancer Institute, Dr. Jimenez was director of the Division of Surgical Oncology at Hartford Healthcare Medical Group in Hartford, Conn. An educator as well, he served as clinical assistant professor of surgery at the University of Connecticut School of Medicine. He has authored numerous peer-reviewed articles and book chapters and has presented abstracts at medical symposiums throughout the U.S. Dr. Jimenez is a Fellow of both the American College of Surgeons and the Society of Surgical Oncology and a member of several professional medical associations.

Professor of Radiology, Sri Ramachandra Medical College Chennai

President    IRIA ,TN & PY Chapter  2013 -14

Senior consultant, Department of Radiology Sri Ramachandra Medical centre and Santosham Chest Hospital Chennai.

MBBS from Stanley Medical College Chennai

DMRD from Madurai Medical college Madurai

Post Graduate Masters degree from Madras Medical College Chennai.

Founder Chairman of Indian Academy of CT interventions.

Founder President SIO ( Society ot interventional oncoradiology ) India

Chairmen: Board of Directors ASTA ( Asian Society of Tumour ablation )

Delivered Invited Guest lecturers  in

CIRSE  ( Cadiovascular and Interventional society of Europe ) 2011  in Munich.

ECIO 2012(European Congress of Interventional Oncology) in Florance.

SYNERGY 2012 (Conference in Multidisciplinary Oncology – Conducted by University of Miami .

ACTA 2017 ( Guangzhou ) China

Delivered Professor Arthur Daniel Memorial Oration in IRIA TN & PY state congress 2012 at Coimbatore.

Invited to write an article “When Robots take over ” in CIRSI( Cadiovascular and Interventional society of Europe ) in 2011.  news paper

Co Inventor of PIGA CT (winner of  Frost & Sullivan 2009 Product Innovation Award)

Joint holder of US patent for PIGA CT with Perfint Health care corporation.

Inventor of HigHNoon: India’s first Non-Robotic CT Navigation Device.( Gold medal winner Medicall 2017 – Best medical innovation award. )

Founder/ Director Kornerstone Devices Pvt Ltd.

Organizing chairman : ACTA 18 Chennai ( Asian Conference on tumor Ablation )

First to perform  Percutaneous Radiofrequency Ablation ( RFA )to treat tumors in the country.

30 publications in peer reviewed journels.

Conducts regular Vertebroplasty & CT guided non – vascular intervention   Hands on Cadaver courses  in India and overseas.

MBBS, MD – Radio Diagnosis/Radiology

Radiologist

26 Years Experience Overall  (21 years as specialist)

Medical Registration Verified

Dr. Aniruddha Kulkarni is a Radiologist and has an experience of 26 years in this field. He completed MBBS from Government Medical College, Aurangabad Maharashtra in 1995 and MD – Radio Diagnosis/Radiology from Government Medical College, Aurangabad Maharashtra in 1999.
He is a member of Indian Medical Association (IMA),IRIA and Indian Federation of Ultrasound in Medicine and Biology (IFUMB). Some of the services provided by the doctor are: Vascular Imaging,General Radiology and Teleradiology etc.

Dr. Chapiro joined the Department of Radiology and Biomedical Imaging as a research scientist and interventional radiology resident from Berlin, Germany. After graduating from the University of Leipzig and upon completion of his research thesis at the Justus-Liebig University in Giessen with summa cum laude, he served as a postdoctoral research fellow in interventional oncology at The Johns Hopkins Hospital and then as radiology resident at the Department of Radiology, Charité University Hospital in Berlin.
Dr. Chapiro’s research focuses on developing new quantitative imaging biomarkers for the diagnosis, characterization, and therapeutic management of liver cancer. His translational research portfolio includes the development of novel embolic agents as well as the application of artificial intelligence solutions for the management of liver cancer. His basic research interest mainly focuses on developing new tools to characterize the tumor microenvironment and the immune system in the setting of loco-regional, image-guided therapies of liver cancer.

innovative and clinically applicable imaging solutions for liver cancer with advanced molecular imaging, image post-processing and machine learning approaches and translating them to clinical practice has been his central mission for the past decade. He authored and co-authored >100 original research articles, reviews and book chapters and gave more than 70 talks and invited lectures within the last five years. His research has also resulted in several patents, 510(k)-approved medical products and significant grant support from federal, foundational and industry sources. He is an active research mentor to more than 30 undergraduate, medical and graduate students as well as peers both at Yale and other national and international institutions. Being an active contributor, journal-, abstract- and grant reviewer in several professional societies (RSNA, SIR and SIO), he is also committed to education and the mission of disseminating research data and scientific knowledge. Dr. Chapiro consults the Editorial Board of the Journal of Hepatology, is a member of the American College of Radiology Liver Imaging Reporting and Data System (LI-RADS) Steering Committee, he additionally serves on the Society of Interventional Oncology Research Committee and is the incoming Chair of the Annual Meeting Program Planning Committee for the Subspecialty of Interventional Radiology at the Annual Radiological Society of North America meeting 2021-2023. He is the co-initiator of the “Rising Star” Student Exchange Program in collaboration with the Charité University Hospital in Berlin and co-directs the Yale Interventional Oncology Research Laboratory. Dr. Chapiro is the Associate Director of the Clinical and Translational Core of the Yale Liver Center.

Education & Training

MD

University of Leipzig (2012)

Departments & Organizations

• Bioimaging Sciences
• Liver Cancer Program
• Radiology & Biomedical Imaging
• Yale Interventional Oncology Research Lab
• Yale Medicine
• Yale University

REGIONAL GUIDES

• America’s Top Doctors (book series): 10th Edition, 11th Edition, 12th Edition, 13th Edition, 14th Edition, 15th Edition, 5th Edition, 6th Edition, 7th Edition, 8th Edition, 9th Edition
• Chicago Magazine: Top Doctors: 2006, 2008, 2010, 2012, 2014, 2016, 2018, 2019, 2020, 2021
• America’s Top Doctors for Cancer (book series): 10th Edition, 11th Edition, 1st Edition, 2nd Edition, 3rd Edition, 4th Edition, 5th Edition, 6th Edition, 7th Edition, 8th Edition, 9th Edition
• Newsweek: 2015
• Castle Connolly America’s Top Doctors (digital guide): 2016, 2017, 2018, 2019, 2020, 2021
• Castle Connolly America’s Top Doctors for Cancer (digital guide): 2016, 2017, 2018, 2019, 2020, 2021
• Chicago Magazine-Cancer Doctors: 2017, 2019
• Chicago Magazine-Aging: 2020

Malagari Katerina graduated from Athens Medical School, National and Kapodistrian University of Athens and got radiology boards in 1990. She had a fellowship in Chest in USA, Birmingham Alabama, and then a second 2-year fellowship in Interventional Radiology in the Dpt of Radiology of the University of Athens. She got her PhD in 1992 and EBIR in 2010. She was a President of ESTI in 2007. She is a member of the editorial board in 5 international journals and got prizes for the “best published study of the year” on five occasions. She was in the team that first introduced EVAR in Greece, and later she focused on interventional oncology. She was awarded the title of distinguished fellow of CIRSE in 2015. She has written 11 greek books and 5 international books. Since 2007 her research work focuses in Interventional Radiology, Chest and Interventional Oncology. She has written 30 articles on chemoembolization and bland embolization of liver tumors, 3 on prostatic embolization, 8 on non vascular liver interventions, 3 on pharmacokinetics, 1 animal study, 16 on chest interventions, 3 on EVAR, and 34 in diagnostic radiology (a total of 98 papers in scopus with an author index 27 and 3.261 citations – 3.162 without self citations. She has 30 publications in greek journals, supervised 46 postgraduate MSCs, 9 PhDs, participated in 9 multicenter project with other European countries and USA. She has a proliferate didactic activity with 103 invited lectures in Greece and 114 lectures in international congresses.

Education

MD, University De Bahia Faculty Medicine – Brazil, 1989

Internship

Internal Medicine, Universidade Federal da Bahia, 1989

Residency

Internal Medicine, University Sao Paulo Faculty Medicine, 1993

Fellowship

Hematology And Oncology, Medical University of South Carolina, 1998

affiliations

American Board of Internal Medicine, Internal Medicine
American Board of Internal Medicine, Medical Oncology
Professor, Hematology and Oncology

Assistant Professor of Interventional Radiology, School of Medicine

Expertise

Radiology
Special focus on
Diagnostic Radiology
Interventional Radiology

Insurance

Before scheduling your appointment, we recommend you contact your insurance company to verify that the OHSU Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any copayments, co–insurance, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with OHSU providers, your out of pocket liability may be higher. Visit the billing and insurance section of our site for more information.

Education

• M.D., 2013, University of Virginia School of Medicine
  ·         Internship:
• University of Virginia Health System, Surgical Internship, 2014
  ·         Residency:
• University of Virginia Health System, Diagnostic Radiology Residency, 2018
  ·         Fellowship:
• University of Virginia Health System, Vascular & Interventional Radiology Fellowship, 2019

Universidad de Buenos Aires

Ricardo Garcia-Monaco, MD, PhD, FSIR, Chairman of Dep of Radiology, Head of Vascular and Interventional Radiology, Hospital Italiano University of Buenos Aires, Program Director of Interventional and Vascular Radiology of the University of Buenos Aires.

Peer reviewer in several journals, including JVIR and CVIR.
Fellow of the Society of Interventional Radiology (SIR)
Member of RSNA Vascular/Interventional Education Exhibits

Chairman of the RSNA Regional Committee for Latin America of the
International Advisory Committee

Honorary Member of the Radiological Society of North America (RSNA)
Honorary Member of the Societa Italiana de Radiologia Medica (SIRM)
Honorary Member of the European Society of Radiology (ESR)
Honorary Member of the Argentine Society of Radiology (SAR)
Honorary Member of the Societe Francaise de Radiologie (SFR)
Gold Medal of the Argentine Society of Radiology (SAR)
Honorary Lecturer ECIO 2019

462 Scientific or Educational presentations in National or International Congresses.
165 Scientific papers published in national or international journals
Author or coauthor of 37 chapters in different books
Editor or author of 25 books

Matthew R. Callstrom, M.D., Ph.D., is a consultant in the Division of Diagnostic Radiology at Mayo Clinic and a professor of radiology at Mayo Clinic College of Medicine. Dr. Callstrom’s research is centered on interventional oncology.

Focus areas

• Percutaneous ablation. A significant area of focus involves the use of percutaneous ablation methods for treating cancer in the liver, kidney, bone, lung and soft tissue. As part of this effort, Dr. Callstrom’s research team has conducted several clinical trials to evaluate the effectiveness of both radiofrequency ablation and cryoablation for palliation of painful metastases involving bone. Three ongoing trials will determine whether cryoablation is beneficial for the treatment of focal painful metastatic disease for patients that have failed conventional therapies, compare the effectiveness of cryoablation with radiation therapy for patients that present with painful metastases, and determine the effectiveness of both radiofrequency ablation and cryoablation for stimulation of a systemic immunological response to metastatic melanoma.
• Image fusing. An additional area of interest is the development of image fusion of previously acquired CT, MRI or PET imaging with real-time ultrasound imaging. This research involves acquisition of 3-D volumes of ultrasound data linked to a magnetic position sensor for correlation with the real-time imaging, image fusion and registration, and development of tools for biopsy and ablation using fusion imaging.

Significance to patient care

Dr. Callstrom’s research contributes to the development of technologies that will allow better identification and treatment of cancer in the liver, kidney, bone, lung and soft tissue as well as indeterminate lesions in the liver and kidney.

Professional highlights

• Editor’s Honorees: Clinical Studies, Journal of Vascular and Interventional Radiology, 2012
• Exemplary mentor certificate, Claremont Graduate University, 2011
• Magna cum laude, Radiological Society of North America, 2011
• Outstanding faculty award, Society of Interventional Radiology, 2010
• Lodwick Award, Musculoskeletal Imaging & Intervention Division, Department of Radiology, Massachusetts General Hospital, Harvard University, 2008

Specialties
Diagnostic Radiology, Vascular Interventional Radiology, Provider Gender

Education & Training

• Baylor College of Medicine (Texas)
• Residency Program, Radiology, Diagnostic, 2020
• Allegheny General Hospital
• Internship Program, Internal Medicine, 2016
• Drexel University College of Medicine (Pennsylvania)
• Medical School, MD, 2015

Radiology Resident, VU Medisch Centrum Academic Medical Center Amsterdam

Expertise:

RFA, Pancreatic Diseases, Radiofrequency Ablation, Computed Tomography, Magnetic Resonance, Biliary Tract Diseases, Liver Diseases, Cholangiocarcinoma, Interventional Radiology, Angiography

Vice Chair, Professor at Medical College of Wisconsin

Specialties
Vascular and Interventional Radiology
Vascular Surgery
Hospice and Palliative Medicine

Overview

Diseases and Conditions

• Kidney Cancer
• Multiple Myeloma
• Osteoporosis
• Sarcoma
• Thrombocytopenia
• Bone Cancer
• Vertebral Fractures

Treatments and Services

• Minimally Invasive Treatment of Genitourinary Diseases
• Transjugular Intrahepatic Portosystemic Shunt (TIPS) Placement
• Minimally Invasive Treatment of Spinal Fractures and Spine Tumors
• Minimally Invasive Pain and Palliative Care Treatments
• Inferior Vena Cava (IVC) Filter Placement
• Inferior Vena Cava (IVC) Filter Retrieval
• Sphenopalatine Ganglion (SPG) Blocks
• Virtual Visit
• Splenic Embolization
• Nerve Ablation
• Bone Ablations
• Minimally Invasive Orthopedic Oncology Treatments

Hospital Affiliations

• Froedtert Hospital – Milwaukee
• Zablocki VA Medical Center – Milwaukee
• Froedtert Menomonee Falls Hospital – Menomonee Falls
• Froedtert West Bend Hospital – West Bend

Board Certifications

• Vascular and Interventional Radiology
• Hospice and Palliative MedicineDiagnostic Radiology

Dr Praveen Peddu is a Consultant Radiologist with a special interest in axial Imaging and hepatobiliary Intervention. His NHS base is King’s College hospital, London. He initially trained as Surgeon and obtained MRCS from Royal College of Surgeons of Edinburgh. He pursued a career in Radiology in London deanery. He completed his radiology training in King’s College hospital and went on to do sub-speciality training in Interventional Radiology. This was followed by a fellowship in Hepatobiliary Radiology at King’s College hospital and was appointed as Consultant in King’s in 2008. Dr Peddu is the clinical lead for HPB imaging since 2018. He reports general axial imaging as well as specialist imaging in post liver transplant and hepatobiliary oncology. He performs complex hepatobiliary interventions and has introduced and developed Nanoknife service.

Dr Peddu is a Honorary Senior Lecturer at King’s College London. He has authored and co-authored peer reviewed papers, book chapters and presented at all European and North American Radiology meetings.

NHS Base (trust)

King’s College Hospital NHS Foundation Trust

Dr. Brian Lally has been practicing Radiation Oncology for 20 years and treats all cancer types, with a focus on prostate cancer and lung cancer. He serves as a co-chair for the Scientific Planning Committee for the American College of Radiation Oncology (ACRO) and was voted to the Board of Challancelors.

He is a strong advocate for his patients and works very closely with them to ensure their well-being from treatment through survivorship.

Recognized by Best Doctors in America 2015, 2016

Expertise

Anal Cancer, Brain and Spine Tumors, Breast Cancer, Cervical and Endometrial Cancers, External Beam Radiation Therapy, Genitourinary Cancer, Liver Cancer, Lung Cancer, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Non-Small Cell Lung Cancer, Pancreatic Cancer, Prostate Cancer, Rectal Cancer, Sarcoma, Small Cell Lung Cancer, Stereotactic Radiation Therapy (SRT), Thoracic Cancer

Assistant Professor of Interventional Radiology, School of Medicine

Expertise
Radiology

Special focus on
Diagnostic Radiology
Interventional Radiology

Insurance
Before scheduling your appointment, we recommend you contact your insurance company to verify that the OHSU Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any copayments, co–insurance, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with OHSU providers, your out of pocket liability may be higher. Visit the billing and insurance section of our site for more information.
Education

• M.D., 2013, University of Virginia School of Medicine
• Internship:
• University of Virginia Health System, Surgical Internship, 2014
• Residency:
• University of Virginia Health System, Diagnostic Radiology Residency, 2018
• Fellowship:
• University of Virginia Health System, Vascular & Interventional Radiology Fellowship, 2019

AJ Gunn, M.D. graduated magna cum laude from Brigham Young University in Provo, UT earning a BS in exercise physiology with a minor in sociology. He then returned home to South Dakota to attend medical school at the University of South Dakota. During medical school, he participated in the competitive Howard Hughes Medical Institute – National Institutes of Health Research Scholars Program and was awarded the Donald L. Alcott, M.D. Award for Clinical Promise. He graduated summa cum laude in 2009. He completed his diagnostic radiology residency at the Massachusetts General Hospital of Harvard Medical School in Boston, MA followed by a fellowship in vascular and interventional radiology at the Johns Hopkins Hospital in Baltimore, MD where he served as chief fellow.

Prior to joining the faculty at the University of Alabama at Birmingham, Dr. Gunn worked as an attending interventional radiologist at Washington University School of Medicine in St. Louis. He has written and lectured regarding patient-centered care in radiology and has interests in the clinical aspects of interventional radiology in addition to patient safety and quality of care. Currently, he serves as the Director of the division’s ambulatory clinic. He serves as a reviewer for multiple journals and as a section editor for a national database of teaching files tailored to radiology trainees. Clinically, Dr. Gunn practices the full spectrum of interventional radiology with a special focus on treating cancer through minimally-invasive techniques such as chemoembolization, radioembolization, and ablation. Additionally, he has interest in IVC filter retrievals and treating women with uterine fibroids.

Afshin Gangi, MD, PhD, is professor of interventional radiology and chief of interventional radiology at the University Hospital Strasbourg, in Strasbourg, France. He is also a professor at King’s College in London, and a member of the Interventional Oncology 360 editorial board. At the 2015 Synergy interventional oncology meeting, IO360 spoke with Dr. Gangi about his specific practice interests and his thoughts on the ways that interventional oncology is growing.

Urologic surgeon with expertise in minimally invasive techniques for the treatment of kidney, adrenal, and prostate cancers. Using laparoscopic, robotic, and image-guided therapies, the goal of our team is to provide appropriate curative therapeutic interventions through the organ-sparing approaches of less-invasive surgery. Interested in the application and careful study of techniques such as robotic (da Vinci) prostatectomy, laparoscopic partial nephrectomy, partial adrenalectomy, cryo- and radiofrequency ablation, and MRI-guided prostate interventions using state-of-the-art instrumentation and imaging technology.

Education
MD, Cornell University Medical College

Residencies
General Surgery – New York Presbyterian Hospital; Urology – New York Presbyterian Hospital

Fellowships
Urologic Oncology – National Cancer Institute

Board Certifications
Urology

Dr. Rebekah White completed medical school and general surgery residency at Duke University. During residency, she worked for three years in a nucleic acid therapeutics laboratory, which would later become the focus of her research career. After general surgery residency, she completed surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center then returned to Duke as faculty in 2007. While her laboratory research was primarily focused on nucleic acids, she became interested in irreversible electroporation (IRE), both as a clinical therapy for patients with pancreatic cancer but also for its potential to help overcome some of the barriers to delivery of nucleic acid therapeutics to tumors. She was recruited to University of California San Diego (UCSD) in 2016 to continue these research efforts, and her laboratory is studying immune responses to IRE and ways to improve them. Her UCSD time is divided roughly 50/50 between clinical and research activities. Outside of UCSD, she is involved in several surgical organizations, including the Society of University Surgeons (as President-Elect) and the Society of Clinical Surgery (as Treasurer).

Dr. Murugesan Manoharan, M.D., FRACS , is a urologic oncologist and the chief of urologic oncology surgery at Miami Cancer Institute. Dr. Manoharan specializes in the treatment of genitourinary cancers, including bladder, kidney, prostate and testicular cancer. Dr. Manoharan also serves as the chairman of the Department of Urology at Baptist Health South Florida and a professor of urology at Herbert Wertheim College of Medicine, Florida International University.Dr. Manoharan is a renowned leader in the treatment of prostate cancer, kidney cancer, bladder cancer and other urologic malignancies.

Dr. Manoharan’s research interests include stem cell applications, biomarkers and cancer outcomes. He serves as an editorial reviewer for several scientific publications. He is also widely published in peer-reviewed medical journals and is an invited speaker at national and international scientific symposiums. Dr. Manoharan has authored more than 140 scientific articles and 15 textbook chapters and has presented papers and posters at more than 100 national and international meetings. He served as vice chairman and a member of the International Bladder Cancer Guidelines committee, organized by the WHO and Société Internationale d’Urologie.

Dr. Andrew Scott Niekamp is a Vascular Interventional Radiologist with Radiology Associates of South Florida and joined the group in July of 2020. He currently practices at Baptist Hospital of Miami, South Miami Hospital and Doctors Hospital.

A native of Ohio, Dr. Niekamp received his undergraduate degree and medical degree from The Ohio State University. He then went on to complete his residency training in diagnostic radiology at the University of Texas at Houston/M.D. Anderson Cancer Center. Following residency, he completed a fellowship in Vascular and Interventional Radiology at the Miami Cardiac & Vascular Institute.

Dr. Niekamp’s interests are in the diagnosis, treatment and management of peripheral arterial disease, venous disease, aortic disease as well as hepatobiliary disease. He is active in clinical research and has published numerous papers encompassing many different aspects of interventional radiology. Dr. Niekamp is also an active member in the Society of Interventional Radiology and has given multiple research and educational podium presentations throughout both North America and Europe.

Dr. Malcolm M. Bilimoria is a general surgeon in Arlington Heights, Illinois and is affiliated with multiple hospitals in the area, including Amita Health Elk Grove Village and Amita Health Adventist Medical Center-Hinsdale. He received his medical degree from Northwestern University Feinberg School of Medicine and has been in practice for more than 20 years.

Dr. Rony Avritscher is an Associate Professor and co-chair of the pre-clinical research program in the Department of Interventional Radiology. Dr. Avritscher earned his medical degree from the University of Sao Paulo, in Sao Paulo, Brazil. He completed his radiology residency at the University of Texas Medical School at Houston and Interventional Radiology Fellowship at MD Anderson Cancer Center and subsequently joined the faculty in 2006. He is certified by the American Board of Radiology and holds a Certificate of Added Qualification in Interventional Radiology.

Constantino S. Peña, MD is an interventional radiologist at the Miami Cardiac and Vascular Institute at Baptist Hospital in Miami Florida where he also serves as the Medical Director of Vascular Imaging. Dr. Peña earned his B.S. and M.S. from the Stanford University Department of Biology in Palo Alto, Calif., prior to earning his medical degree from the Yale University School of Medicine in New Haven, Conn. He completed his residency in Diagnostic Radiology in 1999 as well as a Vascular and Interventional fellowship in 2000 at Massachusetts General Hospital in Boston, Mass. An educator, Dr. Peña is also a Clinical Assistant Professor of Radiology at the Florida International University College of Medicine in Miami as well as a Collaborative Associate Professor of Radiology at the University of South Florida College of Medicine in Tampa, Florida. He is on the Annual Meeting Committee of the SIR. He has served as the Chair of the Cardiovascular Radiology & Intervention Council of the American Heart Association (AHA) and a board member of the IAC CT. He has served on several committees for many professional organizations, including the RADInfo Committee of the ACR and RSNA, the Society of Interventional Radiology (SIR) IO service line, and the Vascular and Interventional Subcommittee Scientific Program Committee (SPC) for the Radiological Society of North America (RSNA). Dr. Peña is a fellow of the SIR, AHA, and SCCT.

Dr David M Liu MD is an Interventional Radiologist with the current appointments of Clinical Professor of Radiology at the University of British. He is board certified in both Canada and the US, and holds appointments at the Vancouver General Hospital, University of British Columbia Hospital and the BC Cancer Agency with a cross appointment in the department of Surgery.

Dr Liu received his medical degree from University of Toronto, completed his radiology residency at University of British Columbia, and interventional radiology fellowship at Northwestern Memorial Hospital, and has practiced on both sides of the border. In addition to benchside and clinical research in the fields of novel embolic platforms, ablative technologies and cancer related thromboembolic disease. Dr Liu maintains an active clinical practice interventional oncology practise incorporating all aspects of embolization, ablation, venous access, and palliative therapy in all organ systems.

He is the co-founder and co-chair of the Symposium HPB Oncology at Whister (SHOW). He has presented internationally, authored book chapters, and publications relating to minimally invasive locoregional cancer therapy. He holds specific interest in the treatment of hepatocellular carcinoma, and metastatic colorectal carcinoma and is actively involved in both translational research and clinical trials.

Edward Kim MD, FSIR is Professor of Radiology and Surgery at the Icahn School of Medicine at Mount Sinai, and is Director of Interventional Oncology in the Division of Interventional Radiology. His clinical research has focused on the field of minimally invasive procedures for treatment of cancer. Through interdisciplinary collaboration with the division of liver transplantation and surgical oncology, numerous publications have been generated related to radiofrequency ablation, microwave ablation, transarterial chemoembolization, radioembolization and electromagnetic tracking for image guidance for the treatment of primary and metastatic liver cancer. Edward Kim participates in multi-center industry sponsored trials that study the use of novel devices for the treatment of liver cancer.

Adeel Kaiser, M.D., is a board-certified radiation oncologist at Miami Cancer Institute. He has expertise in the treatment of a number of solid tumor malignancies, with a special focus on genitourinary and gastrointestinal cancers. He also has significant experience in proton therapy dating back to 2008, when he served as an assistant professor at Loma Linda University Medical Center, the first clinical proton therapy center in the United States. At Miami Cancer Institute, Dr. Kaiser aims to provide patients with a personalized, integrative strategy for their cancer treatment by incorporating complementary therapies with radiation treatment.

Medical School:
1994-1996 Georg-August-University of Göttingen
1996 University of Vienna, Austria
1996-2001 Ludwig-Maximilians-University of Munich (LMU)
1999 University of California San Francisco (UCSF)

Profession:
01/2001- 03/2008 Resident, Department of Radiology, University of Munich; Germany; Prof. Dr. med. Dr. h. c. Maximilian F. Reiser
05/2007- 08/2007 Research Fellowship, Interventional Radiology, MD Anderson Cancer Center, Houston, Texas
04/2008- 12/2010 Section Chief of Angiography and Interventional Radiology; Department of Radiology, University of Munich; Germany
05/2010 Associate Professor of Radiology
01/2011- present Head, Department of Diagnostic and Interventional Radiology, Hospital Brothers of Charity, Munich

Research:
Minimal-invasive Tumortherapy
Radiofrequency ablation of primary and secondary liver tumors
Radiofrequency ablation of lung, kidney and soft tissue tumors
Radiofrequency of benign osseous tumors (Osteoidosteoma)
Vertebroplasty in osteoporotic vertebral fractures
Vertebroplasty / osteoplasty in tumoral osteolysis
Radioembolization of primary and secondary liver tumors

Publications:
95 authorships in national and international peer reviewed journals
• 23 first-authorships
• 67 co-authorships
• 5 last-authorships

10 book chapters:
• 4 first-authorship
• 6 co-authorship

Awards:
• European Radiology, “Most Cited Paper of Volume 12 (2002)”:
• ”Multislice helical CT of the heart with retrospective ECG gating: reduction of radiation exposure by ECG-controlled tube current modulation”
• ESGAR 2004: TOP 50 presenter
• ECR 2009: Winner of the “Rolf W. Günther Foundation for Radiological Science”

Editorial Board:
European Radiology

Reviewer
European Radiology (Eur Radiol)
Journal of Vascular and Interventional Radiology (JVIR)
Journal of CardioVascular and Interventional Radiology (CVIR)
Fortschritte auf dem Gebiet der Röntgenstrahlen und bildgebenden Verfahren (RöFo)

Memberships:
German Roentgen Ray Society
RSNA
ESR
ESGAR
CIRSE

Dr Farah Gillan Irani, (MD, FRCR, FAMS) is Senior Consultant, and Deputy Head of the Department of Vascular and Interventional Radiologist at the Singapore General Hospital. She is also the Service Lead for IR at Sengkang General Hospital, Singapore.
After completing her basic Radiology training in India she obtained her fellowship training in Interventional Radiology in London UK and Toronto Canada. She practices the whole gamut of IR but has special interest in Interventional Oncology, hepato-biliary and Vascular IR.
Dr Irani is an active member of the local Radiology and Interventional Radiology community. In additional to her clinical practise, she is interested in Research and Education helping groom the future IRs of tomorrow.

Dr. Gervais completed her medical training at Tufts University School of Medicine and her residency in Diagnostic Radiology and fellowship in Abdominal Imaging and Intervention at the Massachusetts General Hospital. After a short stay in private practice, she returned to academics as a staff radiologist at Children’s Hospital Boston where her clinical focus was nonvascular interventional radiology. She returned to MGH in 1998 where she has served in numerours leedership positions including as Division Chief of Abdominal Imaging. She currently servers as Associate Chair for Clinical Compliance in the Department of Radiology at the Massachusetts General Hospital. Her research areas of interest include percutaneous tumor ablation, nonvascular abdominal interventional radiology, and imaging for response assessment of oncologic therapies. She is an internationally known expert on the topic of renal tumor ablation and has written and lectured extensively on that topic.

Afshin Gangi, M.D., Hospital of Strasbourg, Strasbourg, France

Dr. Afshin Gangi received his education in the International French School of Teheran, graduating in 1980. During the summer of 1980, he attended medical school at the University of Reims in France, receiving his Degree in 1987. He began his residency in Strasbourg in 1987, first in the intensive care unit and Pneumology where he became excited about imaging and moved to the imaging department. After his Residency in general radiology and Neuroradiology, he worked one year in Luxembourg with Professor R.F. Dondelinger in Interventional Radiology.

Dr. Gangi began his fellowship in Strasbourg in November 1991 in the department of Neuroradiology and MSK with special interest in percutaneous procedures. He performed his first vertebroplasty in 1989 during his residency and continued to develop image-guided procedures in interventional oncology, especially under CT-C arm fluoroscopy and MR guidance. In 1995, Dr. Gangi obtained his Ph.D. in Laser Physics in Strasbourg. During the same year, he was appointed Assistant Professor in the University Hospital of Strasbourg and he became a full Professor of Radiology in 2000. Since 2014, he is working in King’s college London for research in interventional oncology and HIFU as an invited Professor with Professor Andy Adam.

Prof Gangi holds numerous patents and is an author of more that 200 peer reviewed articles. He has more than 35 book chapters to his credit along with over 500 abstracts at numerous national and international conferences.

Currently, Dr. Gangi is the Chairman of Radiology and Nuclear medicine in the University Hospital and work in the department of Interventional Radiology, with a special interest in Interventional Oncology. He is actively involved in different international society and is the vice president of Cardiovascular and Interventional Radiological Society of Europe (CIRSE).

Dr. Brown is Interventional Radiology Section Chief and Professor of Radiology at the University of Utah and works at both the Huntsman Cancer Center and University Hospital. For 26 years she was an Attending Radiologist at Memorial Sloan Kettering Cancer Center, where she established a national as well as international reputation in the field of Interventional Oncology. She is a founding member of Society of Interventional Oncology and member of the Editorial Board of the Journal of HPB. Her primary clinical focus has been on hepatobiliary intervention, with particular interest in local/regional therapy for hepatocellular carcinoma (HCC). She is well known to be a proponent of using embolization with particles/microspheres alone as primary treatment for HCC and for secondary hypervascular liver tumors, including metastatic neuroendocrine tumor, as well as for benign lesions such as hepatic adenoma. Dr. Brown was the Primary Investigator on an NIH supported, prospective, randomized trial of trans-arterial treatment for HCC, the results of which were published in the Journal of Clinical Oncology in 2016. She has a special interest in biliary intervention and has been a strong advocate for percutaneous, rather than endoscopic, intervention with primary stent placement in cases of high bile duct obstruction. Dr. Brown led the weekly hepatobiliary disease management conference at MSKCC for years and continues to attend interdisciplinary conferences in her new position at the University of Utah in order to promote image guided intervention for patients with appropriate indications. Although Dr. Brown sees herself as a clinician educator, and considers sharing her experience with others at meetings, conferences and in the interventional suite as important for the exchange of ideas and the growth and development of the field, she sees her most important role as advocating for and taking care of patients at the University and Huntsman Cancer Center.

Chris Brace, PhD, is an Associate Professor in the Departments of Radiology and Biomedical Engineering, and serves as the Assistant Dean for Graduate Affairs in the College of Engineering at the University of Wisconsin — Madison. His expertise includes applications of elecromagnetics in medicine, microwave tissue heating, medical imaging, multiphysics simulation and translational medical device research. He has authored over 120 manuscripts and book chapters and regularly speaks at international conferences on these topics. He also holds over 20 patents and was a co-founder of NeuWave Medical. Dr. Brace is a senior member of the IEEE, and a member of the Biomedical Engineering Society and Americal Society for Engineering Education.

a.o. Univ.-Prof. Dr. med
Deputy Chairman Department of Radiology
Chief Division of Interventional Oncology / Microinvasive Therapy
Innsbruck Medical University

http://sip.i-med.ac.at
https://www.linkedin.com/in/reto-bale-a4265631/
https://www.researchgate.net/profile/Reto_Bale
https://orcid.org/0000-0003-0021-5792

Academic career history:

Since 2020 Deputy Chairman Department of Radiology Innsbruck Medical University (Chair: E. Gizewski)
Since 2002 Chief Division of Interventional Oncology / Microinvasive Therapy at the Department of Radiology (Chairman: o.Univ.Prof. Dr. Werner Jaschke), Innsbruck Medical University
2002 Board Certification in „Diagnostic Radiology“
2002 Associate Professor of Radiology (Venia legendi)
1996- 2002 Resident in Radiology, University Hospital Innsbruck (Chairman: W. Jaschke)
1995 M.D.- University of Innsbruck, Medical School (A)
1992- 1995 Institute of Anatomy- University of Innsbruck (A)
1993 Prince Charles Hospital- Brisbane (AUS)
1990- 1991 Dissertation Institute of Pathology- University Hospital Innsbruck (A)
1989 Humana Hospital- West Palm Beach (USA)
1989- 1990 Institute of Histology and Embryology- University of Innsbruck (A)

Main research areas and previous research achievements:

Minimal invasive tumor therapy (Radiofrequency Ablation, Alcohol Instillation, Transarterial Chemoembolization, …)
Immobilization, Fixation, Motion artifacts
3D- Navigation, Computer- assisted Surgery, Computer- assisted Interventions, Frameless Stereotaxy, Computer -assisted stereotactic interventional brachytherapy, 3D- surgical planning
Targeting devices for Stereotaxy
Image Fusion: CT- MR- PET- SPECT- Ultrasound

Past research funding:
Österreichische Nationalbank ÖNB 12479: Entwicklung einer Ziel- und Pfadplanungs-Software für minimal-invasive 3 D-navigierte Punktionen EU 40000
MITIGATE FP7 (Nr. 602306) EU 372.800,00 (PI Prof Schönberg)
KM-HYPO, Visipaque- Study, GE Healthcare EU 20000 (PI Doz Widmann)
DOC Funds (FWF AUSTRIA) PhD Program: 2.7 M Euro (PI Prof. Gizwewski)
Additional Functions:
2005- Head of the Working Group “Technique and Innovation” from the Austrian Society of Radiology
2005- Advisory Board of “Archives of Orthopaedic and Trauma Surgery”
2014-2016 President of the Austrian Society of Interventional Radiology (ÖGIR)

Dr Pierre De Marini is an interventional radiologist at the University Hospital of Strasbourg, France in the department of Pr Afshin Gangi. His research interests focus mainly on percutaneous ablative therapies, but his field of clinical interest covers a wide range of interventional procedure including endobiliary and endovascular treatments. He is also a member of the European Training Forum in the CIRSE which aims to promote interventional radiology among medical students.

After completing medical school at the University of Amsterdam he specialized in prostate cancer care through his PhD on focal therapy for localized prostate cancer with irreversible electroporation. He now combines clinical Urology at the Amsterdam UMC with a post doctorate research position at the Garvan Institute and St. Vincent’s Prostate Cancer Centre on various prostate cancer research lines involving multiparametric MRI, PSMA PET CT, immunology, focal therapy, robotic surgery and active surveillance.

Dr. Klevos is fellowship trained in both Breast Imaging and Interventional Radiology. She completed her Radiology residency and fellowships at the University of Miami. Upon the completion of her training, she served in an academic capacity as a faculty member at the University of Miami in Breast Imaging and as the Chief of Breast Interventional Oncology. She is double board certified by the American College of Radiology in Diagnostic Radiology and by the American Board of Internal Medicine.

She has authored and co-authored several peer reviewed journal articles in the fields of both Breast Imaging and Interventional Radiology. She is recognized for her published works in Image Guided Cryoablation of Breast Tumors, Breast Cancer, Treatment of metastatic colorectal cancer with DEBIRI and Irreversible electroporation (IRE) for pancreatic cancer. She is a graduate of the founding class of the PLA (Physician Leadership Academy-South Florida chapter) and has published articles on important topics like Physician Burnout and the ‘Business of Medicine’. Additionally, she has been an invited speaker in multiple national and international medical conferences in the fields of Breast Imaging and Interventional Radiology.

Her current research interest and passion is focused in the field of Breast Cancer and finding minimally invasive treatments to cure breast cancer including Cryoablation.

Assistant Professor of Radiology at Northwestern University Feinberg School of Medicine Chicago, IL

Education

• MS: Northwestern University (2011)
• MD: Northwestern University Feinberg School of Medicine (2006)

Postgraduate Training

• Intern: Cleveland Clinic, Preliminary Surgery (2007)
• Resident: Cleveland Clinic, Urology (2009)
• Postdoctoral Fellow: Northwestern University Feinberg School of Medicine, Interventional Radiology (2011)
• Resident: Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital), Diagnostic Radiology (2015)
• Fellow: Northwestern University, McGaw Medical Center, Vascular and Interventional Radiology (2016)

Certification

• Board Certification: Interventional Radiology and Diagnostic Radiology, American Board of Radiology

As an interventional radiologist, I use image guidance (x-rays, ultrasound, CT, PET, or MRI) to perform minimally invasive procedures. The images are used to direct tiny catheters, wires, and needles in order to diagnose and treat tumors. Using image guidance allows us to perform a wide variety of procedures without making large incisions, leading to shorter recovery times and fewer complications. We can also treat tumors by burning or freezing them (ablation) or clogging the arteries that supply them with different materials (embolization). Other procedures we perform include biopsies, opening an obstructed channel (for example, a vessel, a bile duct, or a ureter), or stopping a bleeding vessel.

I am also trained as a computational biologist, which means I develop, adapt, and apply algorithms from machine learning and information theory to biology. Some of my previous work focused on building mathematical models of biological networks such as gene networks and structural brain networks. Currently I am working on applying these same tools to analyzing genomic data from tumors to better predict and ultimately better tailor treatments to individual patients.

Clinical Interest for Patients I take care of patients with all kinds of bone and soft tissue tumors and cancers, including sarcomas, desmoid tumors, GIST, and PVNS (tenosynovial giant cell tumor). I an an expert not only in standard chemotherapy treatments, but also am active in clinical trials including immunotherapy, and personalized/precision medicine. Care Philosophy I believe that medicine, especially cancer medicine, is best practiced as a partnership between doctors, researchers, and patients. Decisions are always best made as a team effort, taking into account every aspect of a patient’s unique situation! Personal Interests I have recently moved from Miami, Florida to Denver and had to change my hobbies a bit! My husband and I love fishing and boating, and now are getting into exploring the incredible outdoor activities, including hiking, off-roading in our Jeep, learning to ski, and just being outside with our dog! Volunteer Activities I am active with several patient-initiated foundations as an advisory board member, helping to empower patients, families and advocates to advance research to find a cure for sarcomas. Public Speaking Yes I enjoy speaking to patients, families, and physicians in the community to raise awareness of sarcomas and to provide updates on new research including immunotherapy.

Dr. McWilliams obtained his Bachelor of Science in Biology at Truman State University in Missouri, where he graduated valedictorian and Summa Cum Laude. He then attended the David Geffen School of Medicine at UCLA, where he received multiple letters of distinction and was selected for the Alpha Omega Alpha National Medical Honor Society. After completing a transitional internship at St. Vincent’s Hospital in New York City, Dr. McWilliams returned to UCLA for radiology residency. There he served as Chief Resident, and also received awards for Outstanding Radiology Resident and Outstanding Graduating Senior Resident. He then remained at UCLA for interventional radiology fellowship, at which time he also served as Chief Fellow. Upon completion of his fellowship, Dr. McWilliams accepted a faculty position in the interventional radiology department at UCLA. There he splits his time between angio/interventional procedures and cross-sectional interventional procedures, with a focus on HHT, interventional oncology, prostate embolization, vascular disease, dialysis work, and liver interventions.

Dr. David C. Madoff is Vice Chair for Academic Affairs and Professor of Radiology at Weill Cornell Medicinein NYC. Dr. Madoff earned his B.A. from Emory University and his M.D. from the University of Pittsburgh. He completed his internship in Internal Medicine and residency in Diagnostic Radiology at SUNY at Stony Brook. His fellowship training in IR was at MD Anderson Cancer Center. He was on faculty at MD Anderson Cancer Center for a decade before joining Weill Cornell in 2011. From January 2011 to November 2015, Dr. Madoff served as IR Division Chief. Dr. Madoff has a strong background in clinical care and has treated many patients with complex oncological problems. He is world-renowned for his work on preoperative portal vein embolization, a technique based on the liver’s ability to regenerate that has been used in patients with hepatobiliary cancer to increase the size of the anticipated liver remnant before surgery. Without this procedure, many patients with potentially resectable disease would not be eligible for curative resection. Dr. Madoff is a leader in academic IR and an invited speaker at numerous national and international meetings. He authored over 120 peer-reviewed articles, written more than 30 book chapters and served as co-editor of four textbooks. Dr. Madoff served as Deputy Editor for RADIOLOGY from 2012-2017 and Deputy Editor-in-Chief of JVIR from 2007-2010. Dr. Madoff currently serves on the editorial boards of Techniques in Vascular and Interventional Radiology, Seminars in Interventional Radiology, Cancer Biology & Medicine and European Radiology Experimental. Dr. Madoff is active in many major radiological societies including RSNA, ARRS, SIR and AUR and serves on the Board of Trustees of the ARRT. Based on his important contributions to the field, Dr. Madoff was elected Fellow of SIR in 2007, ACR in 2015 and CIRSE in 2017.

Maureen Kohi, M.D.

Chief, Interventional Radiology and Biomedical Imaging

Interventional radiologist

Clinics

Interventional Radiology

505 Parnassus Ave., Room M-361

San Francisco, CA 94143

Phone: (415) 353-1300

Appointments: (415) 353-2573

Billing: (415) 514-8888

Fax: (415) 353-8570

Hours: Monday to Friday

8:30 a.m. – 5 p.m.

Radiology at Divisadero Street

1600 Divisadero St., Room A-142 and A-219

San Francisco, CA 94115

Scheduling: (415) 353-2573

CT, MRI and Bone Densitometry: (415) 885-7282

X-Ray and Nuclear Medicine:

(415) 885-3822

Interventional Radiology:

(415) 885-3578

Fax: (415) 353-7299

Hours: Monday to Friday

8 a.m. – 5 p.m.

Board Certification

Diagnostic Radiology, American Board of Radiology

Academic Title

Associate Professor

More about Maureen Kohi

Education

New York School of Medicine 2005

Residencies

UCSF Medical Center 2010

Fellowships

UCSF Medical Center 2012

Selected Research and Publications

Seo Y, Khalighi MM, Wangerin KA, Deller TW, Wang YH, Jivan S, Kohi MP, Aggarwal R, Flavell RR, Behr SC, Evans MJ. Quantitative and Qualitative Improvement of Low-Count [68Ga]Citrate and [90Y]Microspheres PET Image Reconstructions Using Block Sequential Regularized Expectation Maximization Algorithm. Mol Imaging Biol. 2019 Apr 15.

Wang M, Ballah D, Wade A, Taylor AG, Rizzuto G, Li B, Lucero J, Chen LM, Kohi MP. Uterine Artery Embolization Following Cesarean Delivery but Prior to Hysterectomy in the Management of Patients with Invasive Placenta. J Vasc Interv Radiol. 2019 Mar 25.

Wang M, Laguna B, Koethe Y, Lehrman E, Kumar V, Kohi MP. Bridging the Gender Gap in the Society of IR: A Benchmark Study. J Vasc Interv Radiol. 2019 Feb 27.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.

Dr. Kim is an Associate Professor of Radiology at Georgetown University Medical Center where he serves as the Chief of the Division of Interventional Radiology. After receiving his medical training from Drexel University College of Medicine, Dr. Kim completed a surgical internship at Medstar Georgetown University Hospital. He went on to perform a research fellowship at Memorial Sloan Kettering Cancer Center where he studied various molecular pathways involved in cancer development. He performed his post-graduate training in radiology at Medstar Georgetown University Hospital where he also completed his fellowship in Vascular and Interventional Radiology. His main clinical and research interest is in interventional oncology – specifically to develop methods to augment outcomes from liver-directed therapies – and has published a number of papers on this topic. He currently serves as an investigator in a number of single center and multi-center trials in various interventional oncology treatments.

Dr. Geronemus received his undergraduate degree from Indiana University and his medical degree from the University of South Florida College of Medicine in Tampa, Florida. He completed a residency in diagnostic radiology at the University of South Florida College of Medicine, as well as a fellowship in interventional radiology at Miami Cardiac & Vascular Institute.

Dr. Geronemus is Board-Certified in Diagnostic Radiology with a Certificate of Added Qualification in vascular and interventional radiology.

Dr. Christopher Gomez is a specialist in urinary incontinence and urogenital reconstruction. He earned his medical degree and completed a residency in urology at the University of Miami where he was recognized for his accomplishments in urologic research. He went on to complete a fellowship in female urology, urodynamics and reconstruction. He returned to the University of Miami in 2011 at which point he became a faculty member with the urology department, and in 2012, he became the associate program director of the urology residency program. In 2018 he joined the Miami Cancer Institute to start a center for Continence and Genitourinary Reconstruction. Dr. Gomez was awarded the American Urological Associate/Urologic Society of India academic exchange scholar grant where he focused on urogenital reconstruction in India. He was also selected by the Society of Genitourinary Reconstructive Surgeons and American Urological Society to participate in urethral reconstruction and vesicovaginal fistula repairs in Haiti. He continues to lecture nationally and internationally regarding the impact of neurologic disease on the urinary system and urogenital reconstruction. Dr. Gomez is currently working to advance urologic medicine using minimally invasive surgical techniques to treat benign prostatic hyperplasia, pelvic organ prolapse and urinary incontinence, and he is actively involved in research to test and develop new treatments for these disorders.

Chiara Floridi, MD San paolo University Hospital Milano Born 05.05.1982 M.D., Univeristy of Perugia (110/110 cum laude), 2007 MEDICAL TRAINING Residency in Diagnostic and Interventional Radiology, University of Perugia , 2008-2012 Fellowship in Interventional Radiology Univerity of Insubria-Varese, 2012-2013 PROFESSIONAL EXPERIENCES Physician Consultant at Diagnostic and Interventional Radiology Varese Hospital (2013-2016) Physician Consultant at Diagnostic and Interventional Radiology san Paolo University Hospital, Milano (2016-Present)

Mehul Harshad Doshi, MD, is an Interventional Radiologist at Cleveland Clinic Florida, Weston, and a Clinical Affiliate Associate Professor of Radiology at Charles E. Schmidt College of Medicine – Florida Atlantic University. Dr. Doshi completed his medical school and residency in Radiology from B. J. Medical College, civil hospital, Ahmedabad (India) in 2004. He subsequently completed fellowships in Vascular Interventional Radiology and Neuroradiology from Jackson Memorial Hospital/ University of Miami in 2008. He served as a faculty in the Department of Radiology and Interventional Radiology at the University of Miami from 2008 to 2018. In April 2018, Dr. Doshi joined the section of Interventional Radiology at Cleveland Clinic Florida. Dr. Doshi is Board-Certified in Diagnostic radiology with a Certificate of Added Qualification in Vascular and Interventional Radiology from the American Board of Radiology (ABR). He is a member of the Society of Interventional Radiology (SIR). Dr. Doshi’s areas of clinical interest include Interventional Oncology, TIPS and management of portal hypertension, embolization and ICV filters. His research interests include tissue ablation, chemoembolization, portal hypertension and IVC filters.

Michael Darcy, M.D., Professor of Radiology at Washington University in St. Louis Chief, Interventional Radiology at Barnes Jewish Hospital and the Mallinckrodt Institute of Radiology

Dania Cioni MD Assistant Professor of Radiology at Department of Radiology, Univerity of Pisa Clinical and research activities on diffuse and focal liver lesions buy using contrast ultrasound, computed tomograpy and magnetic resonace imaging, and on interventional oncology procedures and new molecular-targed drug for the treatment of liver malignancies

Jacob Cynamon, MD, Director of Vascular and Interventional Radiology at Montefiore Medical Center and Prof of Radiology at Albert Einstein College of Medicine. Chairman of the AIMsymposium, an annual vascular and interventional radiology symposium held in November in NYC. Currently planning the 27 th year. Research in Dialysis access, Arterial and venous thrombolysis. PI for the Safeflow IVC filter. Seatlle 2 investigator. Recently described a new technique for transvenous liver biopsies- TransFemoral TransCaval (TFTC) liver biopsies One of the team that performed the first Aortic Stent Graft procedure in the US. Current practice is concentrated on interventional oncology, Venous Disease, Women’s health, and Prostate Artery Embolization for BPH.

Undergraduate: University of Miami, School of Engineering Medical School: University of Miami, School of Medicine Residency: Emory University Affiliated Hospitals Fellowship: Cardiovascular and Interventional Radiology at Hospital University Pennsylvania and Children’s Hospital of Philadelphia Board Certification: American Board of Radiology Societies: Radiological Society of North America, Society of Interventional Radiology Specialties: Interventional Radiology with CAQ Dr. Cohn joined Radiology Associates of Hollywood in 1999 after completing his fellowship training from the Hospital at University of Pennsylvania and Children’s Hospital of Philadelphia. His particular area of expertise is in interventional oncology services. Dr. Cohn has pioneered and is responsible for bringing various new interventional oncological procedures to Memorial and south Florida such as: Hepatic Arterial Chemoembolization, Radio-embolization and Radio Frequency/Microwave/Cryo Ablation for oncology patients. He is highly experienced and trains other physicians throughout the U.S.in interventional oncological intervention such as radio-embolization. Dr. Cohn frequently travels as an invited lecturer throughout the United States and has also published several articles. He now serves as Co-Director of Interventional Radiology at the Memorial Healthcare System, Broward County Florida and is an assistant Professor at the Florida Atlantic University Medical School.

Dr. Michael Chuong, MD is a radiation oncologist and director of radiation oncology clinical research at Miami Cancer Institute. He is a member of the NRG Oncology GI committee and the Disease Site Committee Chair for the Proton Collaborative Group. His clinical practice focuses on gastrointestinal cancers for which he has expertise in treating with IMRT, MR-guided SBRT, and proton therapy. He has published numerous peer reviewed manuscripts and is actively involved in clinical trials development.

Dr. Chapiro joined the Department of Radiology and Biomedical Imaging as a research scientist and interventional radiology resident from Berlin, Germany. After graduating from the University of Leipzig and upon completion of his research thesis at the Justus-Liebig University in Giessen, he served as a postdoctoral fellow in interventional oncology at The Johns Hopkins Hospital and then as radiology resident at the Department of Radiology, Charité University Hospital in Berlin. Dr. Chapiro works on the development of novel imaging biomarkers, tumor response criteria, staging systems and molecular imaging techniques for image-guided liver cancer therapies. His translational research portfolio includes the development of novel embolic agents as well as the application of artificial intelligence and machine learning solutions for the assessment of liver cancer. His basic research interest mainly focuses on tumor metabolism and immuno-oncology. With over 50 peer-reviewed publications, book chapters and news articles, Dr. Chapiro advocates the element of personalized medicine in interventional oncology, which is the most rapidly growing field in interventional radiology practice. Creating innovative and clinically practicable solutions and translating them from concept to practice has been his central mission for the past five years. He is the co-initiator of the “Rising Star” Student Exchange Program in collaboration with the Charité University Hospital in Berlin and co-directs the Yale Radiology Research laboratory.

Dr. Jorge Raul Caso is an adjunct assistant professor of urology at FIU and the director of the urologic oncology fellowship and of the kidney cancer institute at the Miami Cancer Institute at Baptist Health. He has lectured in national and international conferences on advanced laparoscopic and robotic surgery for genitourinary malignancies. Dr. Caso has extensive experience in kidney surgery, including the utilization of laparoscopic single site and robotic platforms for nephrectomy and partial nephrectomy. He has particular interest in extraperitoneal and retroperitoneal approaches to renal and pelvic surgery, bypassing intraabdominal approaches where precluded by medical history. He is an expert in performing robotic radical prostatectomy and complex upper and lower tract reconstruction by minimally invasive means. Dr. Caso has published extensively in the surgery and natural history of varied malignancies. His interests include outcomes based-research and novel surgical techniques.

Theresa Caridi, M.D., is an assistant professor in the Division of Vascular and Interventional Radiology at MedStar Georgetown University Hospital in Washington, D.C. After attending the University of Florida for medical school and radiology residency, Dr. Caridi completed a fellowship in vascular and interventional radiology at the University of Pennsylvania. She then joined the faculty at Georgetown. Dr. Caridi is board certified in radiology and also holds her specialty certification for interventional radiology. She currently serves as the medical student clerkship director for interventional radiology at MedStar Georgetown University Hospital. Dr. Caridi is an active member of the Society of Interventional Radiology (SIR) and is presently serving as an officer on the SIR Foundation Board of Directors as the Development Division Chair. She has been named a Washingtonian Top Doctor in 2018, an honor given to her as a preeminent physician in the DC, Maryland and Virginia region. Special interests include the treatment of uterine fibroids and other uterine conditions, pelvic venous congestion/ varicocele, prostate hypertrophy, and pulmonary AVMs.

Jim Caridi MD FSIR, Professor of Vascular and Interventional Radiology and Chairman of Radilogy at Tulane University Medical School. Initial training began at FSU and UF in Florida where he was chief of vascular and interventional radiology for 20 years. Part of this time he also served as fellowship program director. During his tenure along with Dr. I Hawkins and staff they published many peer reviewed articles as well as book chapters and posters. Many of the educational materials centered around improving safety and techniques for vascular and interventional procedures as well being the thought leaders for the use of CO2 as an alternative contrast agent. In 2013 Jim moved to Tulane University Medical Center where he started as an attending in VIR. He has since become Chairman of the Department of Radiology.

James F. Benenati, MD, FSIR, is a practicing Interventional Radiologist, Medical Director, Noninvasive Vascular Laboratory and Fellowship Program Director at the Miami Cardiac & Vascular Institute at Baptist Hospital in Miami, Florida.

He is a Clinical Professor of Radiology at Florida International University College of Medicine and Associate Professor of Radiology at the University of South Florida College of Medicine. He is past President of SIR. He served as President of the Vascular Division for the Intersocietal Accreditation Committee (IAC) and served for over a decade on their board. He served as the annual meeting chairman for SIR in 2005. He was the recipient of the SIR Charles T. Dotter Award in 2014.

He has participated in numerous clinical research projects and national trials. His interest include peripheral arterial disease, abdominal aortic aneurysm and management of pulmonary embolism. He has authored and co-authored more than 100 scientific publications. He has been a Program Director of ISET for over 20 years.

He attended the University of Notre Dame as an undergraduate, received his medical degree from the University of South Florida College of Medicine, completed a residency in Diagnostic Radiology at Indiana University and a fellowship at Johns Hopkins.

Dr. Sandeep Bagla is board certified in Diagnostic Radiology with a Certificate of Added Qualification in Interventional Radiology. He graduated with honors from St. Georges University School of Medicine before completing residency in Diagnostic Radiology at Albany Medical Center where he also served as Chief Resident. Dr. Bagla completed subspecialty training in Vascular & Interventional Radiology at George Washington and completed his Certificate of Added Qualification (CAQ) in Vascular & Interventional Radiology. He has been selected as a Top Doctor in multiple publications, including Washingtonian Magazine. Dr. Bagla is actively involved in clinical research, leading multiple clinical trials and receiving national grant awards. His research interests have included: Prostate Artery Embolization in the Treatment of Benign Prostate Hypertrophy, Soft Tissue Tumor Ablation, Pancreatic Cancer and Pulmonary embolism. He has delivered invited lectures at numerous scientific meetings both nationally and abroad. Dr. Bagla has numerous publications in peer- reviewed journals and currently reviews manuscripts for publication in two major medical journals: Journal of Vascular & Interventional Radiology and Cardiovascular & Interventional Radiology. He has co-authored book chapters on Prostate Artery Embolization and has delivered numerous invited lectures at national and international meetings. Dr. Bagla currently sits on the physician advisory board of multiple worldwide medical device companies providing his advice for the future of cancer and robotic therapy.

Angie Amaro PA-C has been in the field of Intervention Radiology for the last 5 years and is the Chief Physician Assistant of Interventional and Vascular Radiology at Miami Cardiac and Vascular Institute.

I am a Thoracic Medical Oncologist at the Miami Cancer Institute. Board Certified. Member of ASCO and IASLC. Have a special intrest in the treatment of lung cancer.

Board-certified medical oncologist who treats patients with gastrointestinal cancers. Specializing in primary liver cancer (hepatocellular carcinoma), pancreas, gallbladder, and bile duct tumors. As part of a multidisciplinary group, my colleagues and I offer patients a team approach to treating these cancers.

Govindarajan Narayanan, M.D., is an interventional radiologist at the Miami Cardiac & Vascular Institute and the Chief of Interventional Oncology at the Miami Cancer Institute, part of Baptist Health South Florida. He is Board certified in diagnostic radiology and holds a Certificate of Added Qualification in interventional radiology.

Dr. Narayanan received his medical training at Madras Medical College in India. He completed a residency in Nuclear medicine at Methodist Hospital of Brooklyn and Memorial Sloan Kettering Cancer Center in New York, as well as a residency in Diagnostic Radiology at St. Barnabas Medical Center in Livingston, New Jersey. He also completed fellowships in Interventional radiology at Medical University of South Carolina in Charleston and Stony Brook University Hospital in New York.

Most recently, he served as the Chief of Interventional Radiology at University of Miami and Jackson Memorial hospital, and as the founding Chairman of the Department of Interventional Radiology at the University of Miami Miller School Of Medicine, where he also served as a Professor of Interventional Radiology.

Dr. Narayanan’s primary clinical research interests include pancreatic, liver and colon cancer. A member of numerous professional and honorary organizations, he is also a pioneer in his field, developing the technique of percutaneous irreversible electroporation (IRE) of the pancreas. He is widely published in high-impact medical journals as Cancer, Journal of Vascular and Interventional Radiology and Cardiovascular and Interventional Radiology and serves as a reviewer and editor for several scientific publications. He has authored textbook chapters and is an invited faculty member and speaker at several national and international scientific meetings.